About This Report
This is the fourth Sustainability/ESG/Social Responsibility
Report disclosed by Zhonghong Pulin Medical Products Name abbreviations
Co., Ltd. Anchored in the core principles of standardization,
For better expression and readability, “Zhonghong Pulin
transparency, objectivity, and comprehensiveness, this
Medical Products Co., Ltd.” in this report is referred to as
report aims to present to our stakeholders the Company’s
“Zhonghong Medical”, “the Company” or “we/our”.
performance and outcomes in corporate governance,
environmental protection, and social welfare. We hope Subsidiaries involved in this report are:
this report will help foster a deeper understanding of our “Jiangxi Kelun Medical Devices Manufacturing Co., Ltd.”,
sustainability philosophy and operational practices among referred to as “Kelun Medical Devices”;
our stakeholders. We remain steadfast in advancing our ESG “Jiangxi Zhonghong Pulin Medical Products Co., Ltd.”,
initiatives, continuously enhancing our corporate governance referred to as “Jiangxi Zhonghong”;
capabilities and driving high-quality, efficient development. “Guilin HBM Health Protections, Inc.” referred to as “Guilin
HBM”;
Preparation basis “Shenzhen MedRena Biotech Co., Ltd.” referred to as “MedRena”.
Branches involved in this report are:
This report is prepared in accordance with the Self-Regulatory “Tangshan No.1 Branch of Zhonghong Pulin Medical Products
Guidelines No. 2 for Companies Listed on Shenzhen Stock Co., Ltd.”, referred to as “the First Tangshan Branch”;
Exchange—Standardized Operation of Listed Companies on “Tangshan No.2 Branch of Zhonghong Pulin Medical Products
the ChiNext Board , the Self-Regulatory Guidelines No. 17 for Co., Ltd.”, referred to as “the Second Tangshan Branch”;
Companies Listed on Shenzhen Stock Exchange—Sustainability “Tangshan No.3 Branch of Zhonghong Pulin Medical Products
Report (For Trial Implementation) and the Self-Regulatory Co., Ltd.”, referred to as “the Third Tangshan Branch”;
Guidance No. 3 for Companies Listed on the ChiNext Board “Tangshan No.5 Branch of Zhonghong Pulin Medical Products
of Shenzhen Stock Exchange—Preparation of Sustainability Co., Ltd.”, referred to as “the Fifth Tangshan Branch”;
Report , and with reference to the UN Sustainable Development “Tangshan No.6 Branch of Zhonghong Pulin Medical Products
Goals (SDGs), GRI Sustainability Reporting Standards (GRI Co., Ltd.”, referred to as “the Sixth Tangshan Branch”;
Standards) issued by Global Sustainability Standards Board “Tangshan Color Printing and Packaging Branch of
(GSSB) and other relevant standards. It also draws on the ESG Zhonghong Pulin Medical Products Co., Ltd.”, referred to as
topics required by Wind ESG rating. the “Color Printing and Packaging Branch”.
Reporting scope Report access
Unless otherwise specified, the information in this report You can download the Chinese and English versions of this
covers the period from January 1, 2025 to December 31, report from Shenzhen Stock Exchange https://www.szse.cn/
context requires. This report covers Zhonghong Pulin Medical version shall prevail.
Products Co., Ltd. and its subsidiaries and branches.
Feedback
Data source
Please scan the QR code to leave your feedback.
Unless otherwise specified, the data in this report are
sourced from the Company’s internal materials, investigation
and interview records, and other relevant documents. The
Board of Directors of the Company is responsible for the
authenticity, accuracy and completeness of the report and
assures that it is free of false or misleading statements. The
currency used in this report is Chinese Renminbi (RMB).
CONTENTS CONTENTS
Worth Protection by Our Original Mission
Management 54 Win-Win Collaboration
Service with Craftsmanship Honest Operations
for Unity and Strength 66 Indicator Indexes
Message from the Chairman
“
The year wanes, yet a new chapter dawns.
blueprint and built momentum for the next stage of growth. It was also a pivotal year to practice the philosophy of
“operations over management” and to shape the planning for the 15th Five-Year Plan period. We advanced our global
presence, drove progress through technological innovation and grounded our actions in responsibility, translating the
principles of sustainable development—coexisting with society, harmonizing with the environment and advancing
with the times—into concrete practice.
“
In 2025, Zhonghong Medical advanced in harmony with the environment.
Green production is Zhonghong Medical’s sustainability foundation. Leveraging our five major domestic production bases,
we continued to advance equipment automation and process optimization. While ensuring product quality, we achieved
breakthroughs in both capacity expansion and cost reduction. Through initiatives such as energy conservation, consumption
reduction and low-carbon production, we strengthened the foundations of green manufacturing, contributing to the global
green transition of the medical protection industry with efficient, green operations.
In 2025, Zhonghong Medical resonated with the society.
We fulfill our social responsibilities through our commitment to the industry. In Chinese market, we established partnerships
with over 700 new hospitals, building an extensive marketing network that enables high-quality protective products to reach
more primary-level hospitals. Internationally, our “self?development + M&A” global expansion strategy delivered solid results.
Two overseas production bases progressed steadily, while our business footprint expanded to over 100 countries and regions
worldwide, earning global recognition for China’s medical protection technologies and quality.
In 2025, Zhonghong Medical prospered with responsibilities.
We safeguard long-term growth through excellent governance. The Company has diversified its stakeholder engagement
mechanism, deeply integrating their needs into strategic decision-making and risk management, contributing to a resilient
and robust industry ecosystem. During the reporting period, the Company was honored as the Chair Unit of the Latex Branch
of China Rubber Industry Association. Through a standard internal control system with transparent information disclosure, we
strengthened the institutional foundation for steady growth and set a benchmark for industry governance.
Looking ahead, guided by China’ 15th Five-Year Plan, Zhonghong Medical will seize opportunities in global competition, continue
to enhance its presence in the medical protection sector, expand its global industry footprint and enhance international
competitiveness. With the goal of becoming a “forward-looking, intelligent, trusted and time-honored Zhonghong Medical”, we
work to contribute more Chinese wisdom to global healthcare and to write a new chapter of high-quality development with
even greater achievements.
Forge ahead with steadfast dedication, and we will pursue lasting impact through practice.
Chairman
Sang Shujun
About Zhonghong Medical
Company Profile Our History
Zhonghong Pulin Medical Products Co., Ltd.
(“Zhonghong Medical”), founded in 2010,
is a core member of Xiamen ITG Holding
Group Co., Ltd. (one of Fortune Global 500
companies). Focusing on the healthcare Our company was founded. The Sixth Tangshan Branch was established, Continental Medical B.V. Z h o n g h o n g P u l i n
industry, Zhonghong Medical is engaged in W e u n d e r t o o k t h e g l o v e a s s e t s a n d and the first workshop started construction. was established. Medical Products
the research and development, production businesses of Tangshan Zhonghong Pulin The Company was renamed as Zhonghong The Company started the Co., Ltd. was listed
and sales of high-quality disposable Group Co., Ltd., including the First Tangshan Pulin Medical Products Co., Ltd. IPO declaration. on the ChiNext Board
health protection products, medical sterile Branch, the Second Tangshan Branch, the The United Medical Inc was established. The Company started of Shenzhen Stock
equipment, comprehensive life support Third Tangshan Branch, the Fifth Tangshan Jiangxi Zhonghong Pulin Medical Products construction of Jiangxi Exchange (SZSE).
solutions and other medical consumables Branch, as well as Tangshan Color Printing Co., Ltd. was established. Base Phase II.
a n d e q u i p m e n t . D u r i n g t h e re p o r t i n g Packaging Branch. The first phase project of Jiangxi Subsidiary was
period, we had four business divisions, i,e, started, and the second phase project of the
Health Protection, Safe Infusion, Innovative Sixth Tangshan Branch was put into operation.
Incubation, International Development, and
owns seven production bases worldwide,
whose large-scale production capacity can 2023 2022
effectively guarantee stable supply and
continuous after-sales service support.
We have developed a R&D system formed The Company acquired Shenzhen MedRena The Company acquired Guilin HBM Health The Company acquired Jiangxi Kelun Medical Devices Manufacturing Co.,
by Tangshan Research Institute, Shanghai Biotech Co., Ltd. Protections,Inc., to develop latex gloves and Ltd., to expand its business of safe infusion.
Research Institute, Yichun Research Institute, condom products.
Shenzhen Research Institute, Guilin Research
Institute and Hainan Subsidiary. The Company
has been included into the List of State-
Owned Enterprises Selected for the "World-
Class Professional Leader" Cultivation
Program. It ranks among China’s top 50
The Company established Beijing Zhonghong Z honghong Medical Supplies (Hainan) Co., Ltd.(Hainan Subsidiary) was
medical device companies, Top 500 Most
Pulin Reproductive Medical Technology Co., Ltd. established as a medical transformation and R&D platform.
Valuable Chinese Brands, and is recognized
as a national high-tech enterprise. Guilin
HBM is selected as a national specialized and
innovative "little giant" enterprise.
We held equity of Wismed Intelligent Acquisition of a 75% equity stake in Thailand's We signed a strategic cooperation agreement with EverBridge Group to
Technology (Beijing) Co., Ltd and work to Zoupure Medic Company, marking the forge business in product R&D, market expansion and technical services,
establish a long-term and comprehensive Group's first overseas M&A transaction and etc.
strategic partnership with it. accelerating the layout of overseas capital.
Corporate Culture Honors
Zhonghong Medical, deeply engaged Zhonghong Medical Guilin HBM
A future-leading smart Zhonghong Medical
in the healthcare sector, strive to
and a trustworthy centuryold enterprise
become a digital modern enterprise National Specialized and
benefiting all stakeholders and leading Top 50 Medical Device Companies by Revenue Innovative “Little Giant” Enterprise
the industry's future development.
We aspire to become a healthy and China Association for Medical Devices Industry Ministry of Industry and
sustainable century-old enterprise that Information Technology of the
is trusted by customers, employees, Corporate People's Republic of China
partners, shareholders and the society. vision
Guided by the corporate mission, the First-class
leadership Fulfill the High-Tech Enterprise
Company builds a career platform to Hebei Province Manufacturing Top 100 Enterprises in
fulfill employees' dreams of career Authentic Core dream of
Single Champion Enterprise China’s Rubber Industry
responsibility growth for a Office of the Leading Group
development and personal growth. We values Corporate
Diligence first healthy life for the Administration of the
provide the first-class products and mission Hebei Provincial Department of China Rubber Industry
Mutual progress Recognition of High-tech
services to help our customers create Industry and Information Technology Association
Enterprises
a healthy and quality life. We also
operate for good, contributing to the
healthy and sustainable development Top 500 Most Valuable Guangxi 2025 Innovation
of a better society and creating values Chinese Brands Consortium
Pioneer Enterprise Award
for stakeholders constantly.
The Evaluation Center of Brand Department of Science and
CLS
Union (Beijing) Consulting Co., Ltd. Technology of Guangxi Zhuang
nghong charact
Zho ers
Autonomous Region
ept Inn
ov
onc at Listed Company Golden Guilin Innovation
c 2024 Shanghai Securities News
Zhonghong's Bull Award - 2024 Golden Golden Quality ESG Award Consortium
t
io
Guiding
en
G
nc
n Information Disclosure Award
Tal
Aspiration
on
io
Guilin Science and
ui
Principles Shanghai Securities News
rat
Vision
cept
din
's Aspi
Technology Bureau
g Principles o
China Securities Journal
Utmost Sincerity Mission of Pulin
Values
hong
and Excellence,
ng
Achieving ul Altruism, 2024 Yongfu County Enterprise
e pt
fP
ho
Z in
Greatness and 2025 Listed Company ESG 2025 Listed Company Outstanding Award for Outstanding
Qu
Win-Win
nc
y st
Value Communication Award Investor Relations Award
al
co
co
Far-reaching Contribution to High-quality
Co
it
nc
Success e pt Industrial Development
Shenzhen Value Online Shenzhen Value Online
Zho
Information Technology Co., Ltd.
nghong taboos
Information Technology Co., Ltd. Yongfu County Committee of the
Communist Party of China and
Yongfu County People's Government
GoldenBee Excellent Corporate
Sustainability Report 2025 2025 China Talent Management
Customer Responsibility Excellence Award
Information Disclosure Award
Beisen
MedRena
GoldenBee ThinkTank
Talent Innovation Quality Cost
concept concept concept concept
Excellent Board of Directors Award at the 20th Golden Board Award Member of Shenzhen
Utilize employees’ Innovate in Strict quality Lean for Listed Companies in China Association of Medical Devices
strengths integration control management
Hire excellent Transcend in Standards Driven by data Directors & Boards Magazine of Phoenix Publishing and Media Group Shenzhen Association of Medical
talents learning enforcement Devices
Sustainability Management
Double Materiality Assessment
Driven by its ESG strategy, Zhonghong Medical continuously optimizes its sustainability management system. Under a three-tier
governance structure coordinated by the Board of Directors, the Company integrates ESG objectives throughout its business
processes, strengthens stakeholder engagement and accurately identifies stakeholder needs and expectations through regular
surveys and multi-party dialogues. This approach helps us improve our sustainability management mechanism and promote In 2025, building on its previous ESG impact materiality assessment, Zhonghong Medical introduced a dedicated financial impact
cross-departmental collaboration to advance key ESG initiatives. Meanwhile, the Company continues to strengthen its ESG analysis. In collaboration with financial experts, external sustainability specialists and key internal and external stakeholders,
policies and institutional framework, forming a systematic operational approach that enables sustainability strategies from the Company conducted in-depth exchanges to systematically review stakeholder priorities and their financial transmission
planning to execution and translate sustainability principles into solid support for the Company’s long-term value creation. pathways to operating costs, compliance risks, supply chain resilience and brand value. For highly material topics, the Company
established closed-loop management and transparent disclosure mechanisms, promoting the deep integration of sustainable
development with the Company’s business strategy.
Sustainability Management Structure
Based on top-level design, Zhonghong Medical has established a three-tier governance structure — decision-making, management We gather existing ESG practices,
and execution — with the Board of Directors at the core. The Strategy and Sustainability Committee has been established challenges and plans from
under the Board, along with the cross-departmental ESG Task Force, to ensure that ESG topics receive high priority in various departments to create a
corporate decision-making. The Board oversees and makes overall decisions on sustainability-related matters; the Strategy and Dynamical preliminary ESG topic list.
Sustainability Committee is responsible for setting ESG strategic directions and targets; and the cross-departmental ESG Task topic database We refine the list of ESG topics
Force advances and implements specific initiatives. Together, they form a top-down, highly coordinated ESG governance system updates by referring to domestic and
that provides a solid organizational foundation for the Company’s sustainable development. international standards, best
industry practices and ESG
We roll out stakeholder surveys disclosure guidelines.
D eliberate and decide ESG work proposals. through targeted questionnaires We add ESG topics that could
R esearch and judge major ESG risks and opportunities. and daily contacts. significantly impact the Company
Decision- The Board of based on global ESG trends,
Formulate the working procedures of the Strategy and Sustainability We gather from all parties the
making Directors national policies and industry
Committee. concern, risk perception and Stakeholder
O ther responsibilities. improvement expectation for ESG surveys regulations.
topics.
We form a list of stakeholders needs
Study and formulate the Company’s sustainability strategy, manage We evaluate the impact extent,
to provide a basis for subsequent
and oversee sustainability-related impacts, risks and opportunities, and likelihood and scope of ESG
Strategy and assessment.
propose recommendations. topics on the environment, society
Management Sustainability and stakeholders based on the
Review company realities and decide whether the sustainability report
Committee research results.
disclosed by the Company complies with relevant regulations.
O ther responsibilities. Double We quantify the transmission
materiality path and potential impact of ESG
assessment topics on the Company's operating
D efine key objectives and action pathways for the Company’s income, costs, compliance risks
sustainability strategy to ensure that ESG work is aligned with business and brand value.
operations. The ESG Task Force conducts We prioritize ESG topics according
ESG Task comprehensive and representative to the matrix model and screen
D evelop and refine ESG policies, frameworks, and processes.
Force verification on high-priority topics. the highly material topics.
Coordinate internal departments, bring resources together, and drive
sustainability project implementation. The Strategy and Sustainability
Topic
Execution O ther responsibilities. Committee determines the final
deliberation
topic list based on the Company's
and
U nderstand stakeholder expectations and needs timely. strategic objectives and resource
disclosure
E xecute ESG tasks according to established deadlines and schedules. allocation.
Company The Board of Directors finally
Regularly report sustainability practices, performance indicators and
departments deliberates and approves the topic
typical cases.
O ther responsibilities. list.
Zhonghong Medical sustainability management structure Zhonghong Medical double materiality assessment process
Stakeholders Expectations and appeals Ways of engagement
Very significant
Significance to economic, social, and environmental impacts
• Compliance with laws and • Implementation of regulatory policy
Government
• Response to national strategies • Participation in survey and visits
regulations guidelines
and
• Corporate governance • Daily supervision and reporting
• Anti-corruption and integrity • Information disclosure
regulators
• Stable business performance • Shareholders' Meeting
• Sound corporate governance • Periodic reports and information
• Investor surveys and communication
bulletins
Shareholders
• Enterprise risk management
disclosure
• Protection of stakeholder rights • Roadshows and reverse roadshows
meetings
• Responsible marketing system
• Responsible marketing
• Protection of customer rights and • Customer complaint handling
documents
• Product presentation
• Improvement of service quality • Customer discussion and return visits
interests
Customers
• Unblocked service channels • Official website, official WeChat
• R&D of innovative products account, APP and other
communication platforms
Not significant Very significant
• Workers’ congress
Significance to the Company’s financial performance • Employee rights protection • Employee seminars
• Promotion of employee growth • Internal training system
• Occupational health and safety • Performance and compensation
Zhonghong Medical double materiality matrix
Employees
• Compensation and benefits
• Inclusion and diversity • Labor union’s cultural and caring
management system
Environmental Product Social Governance
responsibility responsibility responsibility responsibility
activities
carbon emissions 07 R&D, technology, and and protection of 20 Investor relations
compliance 08 Building a responsible 14 Employee training and 21 Business compliance Suppliers and • Honesty and integrity • Seminars
management supply chain development 22 Business ethics and • Complementary advantages • Signing of agreements
• Mutual benefits • Industry research
partners
discharge 11 Customer privacy Employee care 24 Digital and intelligent
• Implementation of energy saving and
• Energy saving and emission
• Environmental data collection and
• Green manufacturing
reduction
service based charity
Environment
• Green operation • Digital energy management platform
disclosure
Stakeholder Engagement • Green supply chains • Non-profit environmental activities
Zhonghong Medical has established diverse and unblocked stakeholder engagement channels. Business departments take • Sudden disaster and accident • Emergency response training
the lead in conducting targeted dialogue with stakeholders based on their relevance to the medical device industry chain. The • National thematic public welfare
• Devotion to public welfare
response
Company has always been attentive to the concerns and expectations of key stakeholders, including regulators, suppliers, Communities
• Response to social concerns • Charity fund
activities
employees and local communities. We fully integrate their feedback into our operation and decision-making, sustainability
strategy planning, the identification and response to risks and opportunities, as well as the formulation of goals and indicators.
Through collaboration and co-creation, we strive to promote harmonious coexistence and shared growth with our stakeholders.
During the reporting period, the Company identified seven key stakeholder groups: government and regulators, shareholders
and investors, customers, employees, suppliers and partners, environment, and communities.
Spotlight：Digital MedicalIntelligent Healthcare 14 15
Spotlight： Strategy
Zhonghong Medical upholds the transition philosophy of “digitally empowered business and intelligence-driven
Digital Future, Intelligent Healthcare development” and the principle of “customer at center, data at core, efficiency as goal”. We strive to digitalize our
operations through process optimization, technological innovation and data empowerment, thus enhancing operational
efficiency, upgrading management model and delivering greater business value.
Risk Risk Likelihood of Impact Financial Response
In 2025, aligned with its overall development strategy, Zhonghong Medical actively advanced the philosophy of “driving category description occurrence duration impact measures
business innovation through digitalization and enhancing management efficiency through intelligent technologies”.
The Company systematically promoted key initiatives for its digital and intelligent transformation, driving the Regularly conduct
implementation of a number of key digital projects, covering multiple dimensions such as intelligent manufacturing, The rapidly iterating digital Increased initial technology
office coordination, data governance and process optimization. These efforts delivered notable results in improving technologies requires management benchmarking and
Technology
operational efficiency, optimizing operating costs and enhancing management precision, laying a solid digital and higher adaptability of Medium Medium expenses, capability enhancement
risk
intelligent foundation for ESG development. existing systems and affected initiatives, and
application capability. profitability. dynamically optimize
system iteration paths.
Governance Digital transformation
involves cross-departmental
Advance intelligent
process reconstruction
Zhonghong Medical has established the Digitalization Management Department as the core management body for collaboration, and core in phases, implement
Increased
the Company’s digital and intelligent transformation. The department convenes a dedicated meeting each quarter Execution risk business process High Short transitional alignment
operating costs.
to review the progress of digital transformation initiatives, risk assessment results and major actions, and holds a restructuring may lead plans, and promptly
monthly meeting to coordinate and resolve operational issues and track the progress of ongoing tasks. At the same to information gaps and coordinate to resolve
time, the Company enhances employees literacy of digital and intelligent technologies through professional training coordination breakdowns. collaboration issues.
and technical exchanges, building a high-performing and specialized team to manage digital transformation initiatives.
Opportunity Opportunity Likelihood of Impact Financial Response
category description occurrence duration impact measures
Formulate the macro-strategic direction, key decisions and annual work plan The development of
Promote digital
Digitalization concerning digital and intelligent transformation, and regularly oversee and AI, big data and other
reconstruction of
Management evaluate the implementation of relevant work. Technological emerging technologies Decreased
High Long business processes to
Department Act as an executer to lead the implementation of relevant management measures, opportunity provides innovative operating costs.
achieve end-to-end
and build and maintain internal digital and intelligent operation system. solutions for intelligent
digital collaboration.
digital transformation.
Establish a digital
Digital and intelligent management closed-
transformation drives loop system, and
Decreased
Each Management management upgrades, use data to optimize
Work with the Digitalization Management Department to ensure effective High Long administrative
business opportunity enhancing overall resource allocation
implementation of relevant work. expenses.
department operational efficiency and and strengthen cross-
core competitiveness. level management
collaboration.
Digital and intelligent transformation framework
Spotlight：Digital MedicalIntelligent Healthcare 16 17
Impact, risk and opportunity management Building a digital energy management platform
Zhonghong Medical has established a risk management mechanism for digital and intelligent transformation featuring
“strategic guidance – dynamic assessment – targeted measures – closed-loop optimization”. We proactively identify
In 2025, Zhonghong Medical addressed high energy consumption in production by building a digital
risks and opportunities related to digital and intelligent transformation. Through phased implementation, integrated
energy management platform that can collect, monitor and analyze real-time data on electricity, and
resource allocation, and performance evaluation, we ensure risks are effectively controlled and opportunities are
gas usage. The platform also automatically detects abnormal energy consumption and issues alerts,
captured, securing the solid delivery of transformation outcomes.
helping production teams optimize energy usage. During the reporting period, the Company significantly
reduced energy consumption per unit of product year-on-year, achieving both cost reduction and green
development goals.
Building a digital platform Digitalizing business processes
We have built a unified data hub that integrates
internal and external data. Our standardized
We digitalize and optimize our core business
processes, and work to eliminate information Metrics and targets
data warehouse enables centralized data silos, achieving full-process digitalization
management and sharing, providing data across order management, manufacturing, In response to China’s intelligent manufacturing strategy, Zhonghong Medical continues to increase investment in
support for business decision-making. logistics and customer service. digital transformation. The Company is building advanced digital factories, and introducing intelligent production
equipment and management systems to automate production processes. Through these efforts, we work to fully
leverage digital technologies to improve efficiency and precision, reduce costs and risks, and contribute to the broader
advancement of digitalization.
Digitalizing manufacturing Promoting digital office
We p r o m o t e i n t e l l i g e n t u p g ra d e s i n We leverage digital office tools to enable
manufacturing through an industrial internet mobile work for all employees, and have built a
platform that realizes data collection, collaborative platform that supports workflow
analysis and precise control of production approvals, document sharing, instant
equipment, improves quality control and messaging and meeting management.
reduces energy consumption.
Corporate digital and intelligent transformation
Building a financial shared service center
In 2025, Zhonghong Medical established and launched a financial shared service center. By integrating
company-wide finance functions, including accounting, expense reimbursement and cash management,
the center centralizes and analyzes financial data in real time, standardizes and automates processes,
and enables online submission, intelligent review and automatic payment of expense claims, boosting
accounting efficiency by 60% and significantly reducing human errors.
A Green Defining
Feature Worth
Protection
Committed to green development, Zhonghong Medical continuously
improves its environmental management system, compliant
operations and risk prevention. The Company enhances resource
management efficiency through technological innovation and
process optimization, achieving intensive and circular resource
utilization. We focus on key pollution control measures to strictly limit
emissions, and upgrade end-to-end governance from source
reduction to process control, contributing ecological restoration and
harmonious coexistence between human and nature.
Material topics
Environmental compliance management
Climate change and carbon emissions
Resource utilization
Waste and pollutant emissions
Green office
Contributions to UN SDGs
Environmental Compliance
Management Opportunity Opportunity Likelihood of Impact Financial
Response measures
category description occurrence duration impact
Governance Green
Market demand for
biodegradable, low-
Increased
revenues,
Increase investment in green manufacturing,
build green factories, and develop recyclable
manufacturing pollution medical High Long increased and biodegradable solutions for disposable
Zhonghong Medical has established and obtained ISO 14001 certification for its environmental management system. With sound opportunity protective products market protective products to reduce environmental
EHS management systems, our subsidiaries have formed multi-tier oversight mechanisms that include routine supervision, continues to grow. shares. costs per unit of output.
environmental impact assessment and environmental monitoring. They have incorporated environmental management
indicators and targets into their management performance evaluations to comprehensively enhance environmental
management capabilities. In 2025, the Company reported no environmental administrative penalties, pollution incidents or major
environmental accidents. Impact, risk and opportunity management
Zhonghong Medical systematically reviews environmental risks in its operations, assesses risk levels and implements targeted
As the primary person responsible for the Company’s environmental protection efforts, mitigation measures. Through regular monitoring and dynamic control, the Company continuously refines its response strategies
General Manager the General Manager is responsible for formulating and communicating environmental and has established a management framework incorporating pre-warning, in-process response and post-optimization to
management policies. effectively prevent compliance risks and environmental incidents.
Led by the Safety and Environmental Protection Department, the team is responsible
Environmental for the inspection, department coordination, data analysis, renovation and upgrading of
Leadership Team environmental protection facilities, etc., to ensure the compliant disposal of the three We have established environmental factor identification procedures to comprehensively, correctly
wastes and the discharge of pollutants. and effectively identify environmental factors throughout the Company's activities, products and
Environmental
factor services.
Company departments are responsible for promoting and implementing specific
Company Departments identification We carry out comprehensive environmental factor reviews and updates every year to ensure
environmental management tasks.
effective identification.
Environmental governance structure
Strategy Environmental
incident
We have formulated environmental emergency plans for hazardous waste and other factors, and
regularly carry out emergency drills against environmental incidents such as pollutant leakage
prevention and hazardous waste fire every year to improve our response to environmental emergencies.
Following the philosophy of “green development and compliance first”, Zhonghong Medical has established an integrated
management system covering compliance management, resource conservation and pollution prevention. Guided by
laws and regulations, the Company continues to strengthen environmental governance through institutional frameworks,
technological optimization and process control. We aim to promote energy conservation and recycling measures and implement
comprehensive monitoring and precise pollution control, thus achieving coordinated economic and ecological benefits. Environmental
monitoring
Emission abnormalities are pre-warned through internal real-time monitoring system.
and
Risk Likelihood of Impact Financial inspection
Risk description Response measures
category occurrence duration impact
The medical consumables industry Continuously upgrade waste gas and
faces stringent environmental
Increased
wastewater treatment systems, introduce
Environmental risk control process
Pollutant operating
compliance requirements; delayed industry-leading environmental protection
control Medium Medium costs,
risk
upgrades in treatment processes
or inadequate controls may lead to
decreased
revenues.
treatment technologies, and establish a
real-time monitoring system for pollutant Metrics and targets
excessive emissions. emissions throughout production.
Introduce bismuth-based catalysts and Environmental governance target Progress in 2025
The development of new technologies
soft-hard segment gradient design to
and products is time consuming; Increased Compliant exhaust gas emissions Fulfilled
Process develop low-consumption, low-emission
pilot production may generate High Long operating
risk technologies and products that can Compliant wastewater discharge Fulfilled
pollutants; process bottlenecks can costs.
improve resource efficiency and reduce
lead to low resource utilization.
pollutant emissions. Compliant waste disposal Fulfilled
Resource Conservation
Efficient resource utilization is Zhonghong Medical’s core driver for environmental protection. Through strategic planning and Our Scope 1 emissions primarily result from the combustion of fossil fuels, including gasoline, diesel, natural gas, and coke oven
technological innovation, the Company has established a refined, full-chain management system covering energy, water and gas. Scope 2 emissions arise from indirect emissions associated with purchased electricity and steam.
materials, supporting low-carbon transition.
In 2025
Energy management Total GHG emissions Scope 1 GHG emissions
Zhonghong Medical leverages technological innovation and refined management practices to optimize energy parameters and 851,780.57 tCO2e 3,206.49 tCO2e
production process adaptability. The Company actively promotes energy-saving technologies and eco-friendly equipment,
strengthens employee awareness and advances initiatives across multiple dimensions—from technology application and GHG emissions intensity Scope 2 GHG emissions
equipment upgrades to personnel management—achieving both energy and emission reductions as well as cost optimization.
tCO2e/RMB 10,000 tCO2e
Guilin HBM promotes energy conservation and carbon reduction
Water resource management
Guilin HBM has achieved energy conservation and carbon reduction by optimizing both production and public utilities. On
the production side, automatic temperature control systems are installed to adjust the fan inlet temperature of ovens in real Zhonghong Medical strictly complies with laws and regulations such as China’s Water Law . Guided by the principles of science-
time, precisely managing energy demand and reducing steam consumption. On the utilities side, manual monitoring and based water management and water conservation first, the Company advances water resource management by exploring
intervention are applied to central air-conditioning and chiller units, dynamically adjusting return water temperatures and effective approaches and increasing investment in water resource protection. Watersaving and consumptionreduction
reducing unit operating frequency to prevent increased electricity consumption caused by weather fluctuations. requirements are fully integrated throughout its production and operational processes to build a waterefficient enterprise. The
Company’s primary water sources are municipal water supply and ground water, and all water withdrawal and drainage activities
do not have any significant impact on water resources.
Indicator Unit 2025 In 2025
Total energy consumption tce 257,653.20 Total water consumption Domestic water consumption Industrial water consumption
Direct energy consumption
Indirect energy consumption
tce
tce
Packaging material management
Gasoline liter 23,514.98
Diesel liter 61,129.77
Natural gas m3 110,630.45 Upholding the environmental sustainability philosophy, Zhonghong Medical has implemented environmental requirements
throughout the entire process from material selection to packaging recycling. The Company prioritizes low-VOC, an eco-friendly
Coke oven gas m3 3,203,744.00 raw and auxiliary material, and strictly follows relevant standards to ensure quality. We implement the packaging recycling
mechanism by requiring suppliers to collect and reuse packaging boxes, reducing waste generation. Meanwhile, we strengthen
Purchased electricity MWh 398,951.91
supplier environmental assessments, enforce green procurement and offer employee training to improve resource efficiency
Steam ton 2,138,596.71 and fulfill our environmental responsibilities.
Guilin HBM launches “Plastic and Carbon Reduction”
packaging upgrade project
Guilin HBM launched the “Plastic and Carbon Reduction” packaging upgrade
In 2025
project, adopting an FSC-certified kraft paper card combined with a recyclable
Packaging material consumption PE window film in a non-laminated structure. Product information is printed with
soy-based ink, replacing traditional laminated film packaging to reduce heavy
metal pollution. The new packaging has received positive customer feedback.
tons
Waste and Pollution Control Green Offices
Zhonghong Medical has established such regulations as the Hazardous Waste Prevention Responsibility System and Wastewater, To build green offices, Zhonghong Medical promotes energy and carbon reduction practices including digital operations, energy
Waste Gas, and Noise Pollution Prevention and Control Procedures. These documents define the emission standards, monitoring management, green commuting and environmental education. The Company continuously optimizes office operations to reduce
mechanisms and treatment processes for pollutants including waste gas, wastewater, solid waste and noise. The Company resource consumption and carbon emissions, fostering a low-carbon, eco-friendly work environment.
has built a closed-loop system of “monitoring and early warning, targeted control, strict management”, supported by multi-
dimensional monitoring mechanisms for wastewater, waste gas, noise and waste. The systems enable real-time collection and
uploading of emission data with anomaly alerts, while clearly defining concentration and total discharge limits to ensure real- Green office measures
time tracking and dynamic supervision of pollutant emissions.
In 2025 Green office
Total wastewater Introducing paperless offices through information system.
Industrial wastewater Domestic wastewater
Implementing double-sided printing to reduce the use of printing paper.
m3
P
emissions arising from business travel.
Total solid waste
Non-hazardous waste Hazardous waste
tons
Green electricity
ptimizing energy-consuming equipment and consumption management, purchasing
O
high energy-efficient air conditioners, and setting the cooling temperature in summer to
Pollution prevention and control measures no less than 26 ℃ .
enovating the lighting system, installing energy-efficient bulbs, and ensuring lights are
R
switched off after working hours to reduce office electricity consumption.
Waste gas Wastewater Solid waste Noise Green commuting
Installing EV charging piles at manufacturing sites and parks to encourage the use of
or emissions from
F pgrading production
U azardous waste:
H ptimizing industrial
O new energy vehicles.
coal-fired boilers, process to reduce entrusting qualified layout, and tightening ncourage employees to commute via public transport, shared bicycles and other green
E
volatile organic hazardous waste professional agencies with noise protection modes of mobility to reduce carbon emissions.
compounds and other emissions. the harmless disposal of measures.
air pollutants, applying Promoting wastewater hazardous waste, strictly Tightening prevention
tailored combined treatment technology following compliant and control of vehicle
treatment processes and equipment to transfer procedures as noise, and introducing
Green culture
for efficient purification improve efficiency. well as establishing and low-noise engines
to achieve compliant Separating storm maintaining detailed and sound insulation arrying out regular publicity on ecological conservation, energy saving and carbon
C
emissions. and sanitary sewer management records. equipment. reduction to raise green development awareness.
systems, and installing Non-hazardous waste:
Organizing afforestation and waste sorting campaign to practice the green philosophy.
sewer pipelines and prioritizing classified
rainwater ditches. recycling, entrusting
qualified agencies with
the recycling of such
Extended reading recyclables as corrugated
paper and packaging lining
For more pollutant discharge information, please paper, and entrusting
refer to Zhonghong Medical Annual Report 2025 . environmental sanitation
departments to handle
other non-hazardous waste.
Quality at Our Core
and Service with
Craftsmanship
Zhonghong Medical strictly controls the entire product
quality process and proactively establishes a
standardized and responsible supply chain system. We
improve an efficient and convenient customer service
response mechanism to enhance customer experience
and satisfaction, while systematically mitigating potential
risks in quality control, supply chain operations, and
customer service. With customer demands as the core
driving force, we upgrade our product innovation and
services to strengthen our brand resilience.
Material topics
R&D, technology, and innovation
Product quality and safety
Building a responsible supply chain
High-quality customer service
Responsible marketing
Customer privacy protection
Contributions to UN SDGs
Innovation-driven Development
Governance Opportunity
category
Opportunity description Likelihood
Impact
period
Financial
impact
Response measure
Increased efficiency in the We have established an
Zhonghong Medical regards its research institutes as the core departments for innovation and R&D management, namely, the
conversion of R&D achievements, evaluation mechanism for
Tangshan Research Institute, Shanghai Research Institute, Yichun Research Institute, Shenzhen Research Institute, Guilin Research
with patented technologies and the conversion of R&D
Institute, and Hainan Subsidiary, which form its R&D system. The research institutes oversee the entire R&D process, including Technology Increased
core processes being industrialized, Medium Long-term achievements to track the
organizing the formulation of annual R&D plans, promoting project initiation, conducting R&D, and facilitating project evaluation, opportunity revenue.
will form a unique technological results and continuously
and patent applications. In terms of personnel, the Company recruits specialized talent with master's and doctoral degrees, builds
advantage and continuously optimize the technology
innovation platforms, and refines promotion mechanisms, forming a multi-departmental collaborative R&D team that covers
strengthen core competitiveness. implementation process.
production, technology, sales, and management. The responsibilities of R&D personnel are clearly defined. Additionally, the Company
has established R&D management regulations such as the R&D Management Measures , Reward Measures for R&D Achievements ,
and the New Product Development Management Measures , ensuring the professional capabilities and motivation of the R&D team.
Ultimately, they will support the Company's technological development and strategic layout in the medical device field.
Risk, opportunity, and impact management
Strategy Zhonghong Medical consistently integrates the management of R&D risks and opportunities into the entire innovation process.
Grounded in strategic development, the Company keeps a close eye on industry trends and market demand, enhancing overall
Guided by the innovation concept of "innovate in integration and transcend in learning", Zhonghong Medical focuses on planning and systematic analysis. We work to prevent and resolve various potential risks while accurately identifying and seizing
formula optimization, process upgrades, and functional expansion to meet market demands and be at the industrial frontier. By development opportunities, ensuring the steady progress of R&D innovation activities.
integrating internal R&D platforms' talent, equipment, and data resources, the Company connects the chain of R&D, pilot testing,
and industrialization to quickly transform technological achievements. With continuous learning as the core driving force, we
strengthen frontier technology research and reserves through industry benchmarking, technical exchanges, and employee Identification Evaluation
training, striving to expand product lines and enhance the core competitiveness of our products. Furthermore, to enable open
innovation, we improve internal multi-departmental collaborative R&D mechanisms and full-process management systems,
e analyze technological bottlenecks in
W e quantify and analyze the risks and
W
stimulating the vitality of all employees through tiered incentive policies. Externally, Zhonghong Medical actively collaborates
R&D and assess the reserve of cutting- opportunities related to R&D innovation.
with universities, technical teams, and other external innovation resources. Joint R&D and technological cooperation is launched
edge technologies. We systematically summarize key
to overcome industry technical bottlenecks.
We conduct research on market demand, information about risks and opportunities
competitor dynamics, and policy trends, and identify priority areas.
Risk Impact Financial and collect customer improvement
Risk description Likelihood Response measures
category period impact
requests.
Weak self-innovation capability, e analyze the need for production
W
We regularly conduct business
insufficient forward-looking process optimization and potential
training, cross-enterprise
research on cutting-edge industry Sluggish
Technology technology exchanges, and industry cost-reduction opportunities. R&D risk
technologies, notable gaps in core Medium Long-term revenue We assess risks related to R&D
risk benchmarking to systematically management
technology reserves, lead to the growth. input-output and compliance costs.
improve the technology level of the
difficulty in quickly responding to
R&D team.
process
technological iteration demands.
Adequate insight into market demand, We have established a coordination Review Response
and lack of predictive ability regarding mechanism between the sales,
market trends and potential customer Medium- Revenue marketing, and R&D departments to
Market risk Medium e conduct a comprehensive review
W e develop specialized plans to
W
needs, result in a disconnect between term decline. share market demand information
product development and actual in real time and accurately capture and evaluation of risk and opportunity address risks, including technology
market demand. potential customer needs. response effectiveness, resource enhancement, demand insights,
investment, and any issues encountered. and compliance control, and drive
We strictly enforce the R&D We summarize lessons learned and opportunities such as pilot testing of
Gaps in full-process compliance
Management Measures and optimize the R&D process, reward new products, process optimization,
management in R&D, including
Increased standardize the entire process from mechanisms, and risk control systems. project applications, and collaborative
Management nonstandard project initiation Short-
Low compliance project initiation, implementation, We update the risk and opportunity list R&D efforts.
risk approvals, delayed archiving of term
costs. and completion to results and incorporate it into the next year’s We create project execution plans, clearly
R&D documentation, and weak
transformation, ensuring each step R&D plan. defining roles and timelines.
budget control.
is properly managed.
Promoting
technological
Strengthening
Reliable Products
product R&D
innovation
We have conducted research on latex applications, We have launched low-weight, high-end nitrile gloves Governance
v u l c a n i z a t i o n t e m p e ra t u r e s , a n d o t h e r p r o c e s s to fill gaps in niche markets and meet diversified health
technologies. Through refined control of the vulcanization protection needs. Zhonghong Medical has established a product quality governance framework, creating a quality management network that
process, we have reduced production energy consumption involves all employees, from senior leadership to frontline staff. In accordance with domestic and international medical device
and quality fluctuations, while improving the mechanical laws, regulations, and standards, the Company has developed a product quality management system that includes quality manual,
properties and durability of products. procedure documents, management system, and operation documents. In 2025, the Company proactively accepted external
We have established internal safety testing methods for supervision by engaging third-party agencies to conduct annual external audits. Zhonghong Medical has successfully passed
food-contact nitrile gloves to ensure product compliance and several international certifications, including the EU CE marking, US FDA certification, ISO 9001 quality management systems,
consumer safety. ISO 13485 medical devices quality management systems, Medical Device Single Audit Program (MDSAP), and BRC certifications,
among others. We continuously improve our product quality management system(QMS) to ensure its suitability, adequacy, and
effectiveness. Zhonghong Medical has formed a cross-departmental product quality management team composed of members
with expertise in various fields. This team includes department heads, technicians, quality inspectors, internal auditors, sales staff,
Guilin HBM's dual projects selected for innovation consortium warehouse managers, after-sales service personnel, procurement staff, and production operators. They oversee product quality
from different perspectives, enabling comprehensive and refined management throughout the entire product life cycle.
In 2025, Guilin HBM continued to prioritize "enterprise-driven, market-oriented, and deeply integrated industry-
university-research collaboration" as the core approach to technological innovation. It actively participated in
technological breakthroughs and resource integration. Two of Guilin HBM's projects, "Guangxi High-Performance
Polymer and Biodegradable Materials Innovation Consortium" and "Guilin High-Performance Latex Application
Technology Innovation Consortium", were successfully selected for the 2025 Innovation Consortium list of the Guangxi
Zhuang autonomous region and the second batch of Guilin's innovation consortium, respectively. These projects aim
to achieve more breakthroughs from "0" to "1" in key fields.
Guilin HBM's third-generation PI material introduced
Common medical gloves and condom materials on the market are primarily made from natural rubber latex, which
generally presents issues such as poor user experience and protein allergy risks. Guilin HBM has independently ISO 9001 quality ISO 13485 medical device MDSAP certification British Retail Consortium
developed its third-generation polyisoprene (PI) material, which offers multiple advantages including superior management systems quality management system (BRC) certification
softness, better skin contact, no allergy risks, and high elasticity. This innovation provides consumers with an certificate certificate
unprecedented level of comfort and safety.
As the highest authority in the Company's QMS, the general manager is responsible
General
Metrics and targets
for defining the roles and responsibilities related to product quality management and
manager
ensuring the necessary independence and authority for accomplishing these tasks.
Zhonghong Medical focuses on breakthroughs in core technologies, tackling critical challenges in the health protection field. By Commissioned by the general manager, the management representative is fully
benchmarking international advanced standards, the Company aims to create a product matrix that combines innovation and responsible for the daily operation, maintenance, and oversight of the Company's QMS.
Management
competitiveness. With continuous investment in R&D, we strive to empower our global market expansion and contribute to the This role coordinates quality-related work across departments, ensuring the system's
representative
innovative upgrading of the healthcare industry. conformity and effectiveness, while promoting the implementation of corrective and
preventive actions.
In 2025
R&D Patents obtained Invention Utility model Design Company Each department is responsible for advancing and executing specific product quality
R&D investment personnel in total, including patents patents patents departments management tasks.
RMB 113.1865 million 625 240 64 128 48 Product quality governance framework
Strategy We identify potential risks, opportunities, and stakeholder demands across various stages, including
design, procurement, production, inspection, and delivery, and develop response strategies.
Identification We map the sequence and interconnections of QMS processes, and identify the risk transmission
Zhonghong Medical's product quality management strategy focuses on the core principles of "system optimization, risk
and analysis paths between processes.
prevention, efficiency improvement, and sustainable improvement." The Company aims to ensure product quality stability,
Based on stakeholder demands, we define the responsible parties and control authorities for risk
compliance, and efficiency while supporting business expansion through digital transformation, supply chain enhancement, and
management within the product quality management process.
capacity building for all employees.
Impact Financial We analyze identified risks and opportunities, and assess the likelihood, impact period, severity,
Risk categry Risk despcription Likelihood Response measures
period Impact and risk level of potential risks.
Increased We have built a company-
Evaluation For each risk level, we predefine corresponding control measures, clarify operational guidelines,
Misinterpretation or inadequate and methods, and monitoring and measurement requirements, and create product quality risk control
compliance wide quality awareness system,
implementation of national prevention documentation.
costs, strengthened employee
medical device laws and We allocate the necessary resources and information in advance for effective product quality risk
Policy risk Low Long-term revenue understanding of ISO standards,
regulations, leads to product management to ensure that control measures can be implemented.
decline, and PPE, EN455, and other regulations,
recalls, public penalties, or
reduced and enhanced overall quality
production stoppages.
market share. awareness.
We implement product quality management processes in accordance with the requirements
We have established an efficient outlined in the product quality risk control documentation to ensure compliance with risk
Substandard product quality Revenue customer complaint response Control prevention protocols in operations like production and inspection.
leads to decreased public and decline, and mechanism, improved processing and We conduct daily monitoring of quality risk points for key products, collect process data in real-
Trust risk consumer trust in the Company Medium Long-term decreased efficiency, and strengthened the response time, and promptly identify abnormal risk signals.
and its products, damaging market use of digital tools, shifting from W hen product quality risks trigger an early warning, we initiate the emergency response
brand reputation. value. traditional responses to data- mechanism and take immediate actions to contain the risk's spread.
driven preventive management.
Product quality risk management process
Incomplete identification of Increased
We prioritize the development and
stakeholder demands, leads to operating
Management Medium- maintenance of a multi-standard
blind spots in product quality Medium costs, and Quality inspection Management capability Market recognition Assessment mechanism
risk term QMS, and dynamically adjust it
control and failure to meet revenue process optimization enhancement improvement guarantee
based on stakeholder feedback.
external quality requirements. decline.
We h a v e i n c r e a s e d t h e We have conducted 12 quality- We h a v e c o m p l e t e d 3 8 We regularly inspect factory
incoming inspection project focused training sessions, outsourced tests and obtained production, quality control,
Opportunity Impact Financial of raw material and auxiliary covering nearly 900 people. PPE extension certificates and equipment status,
Opportunity description Likelihood Response measures
catogory period impact
materials and introduced Training topics include ISO from 10 customers to ensure incorporating the results into
We eliminate non-compliant related equipment. We also standards, PPE, EN455, and product quality complies with performance evaluations
suppliers, improve the Lower updated Standard Operating other regulations, with a focus standards. to ensure stable factory
We use a supplier auditing system
Supply chain quality and safety of the operating Procedures (SOPs) for key on reinforcing SOP training for operations.
Medium- to identify and reduce supply
optimization supply chain, enhance High costs, and processes such as mixing production control personnel
term chain quality risks, and eliminate
opportunity product quality stability, and increased and dipping, and refined and quality risk assessment
non-compliant suppliers.
strengthen the Company's core revenue. parameter standards. methods for management.
competitiveness.
Metrics and targets
We strengthen quality Increased We increase investment in quality
Brand assurance capabilities, increase revenue, technologies, and upgrade quality
High Long-term
opportunity public and consumer trust and and higher testing equipment and control
loyalty in the products. market value. systems. In 2025 Product quality management Progress in
indicator 2025
Nitrile product return rate Below 0.2% 0% Achieved
Risk, opportunity, and impact management
Quality training coverage rate Above 95% 100% Achieved
business scope covered by
the QMS certification for the Order delivery timeliness rate Above 90% 95.76% Achieved
Zhonghong Medical has established product quality risk control systems, including the Risk Control Procedure and Risk and sixth consecutive year. Product customer satisfaction rate Above 95% 99.91% Achieved
Opportunity Response Control Procedure , to create a closed-loop management system that covers risk identification, early Procurement product pass rate Above 98% 100% Achieved
warning response, and emergency handling. This system proactively prevents quality risks through a systematic mechanism, No product withdrawals
or recalls occurred. External audit pass rate Above 98% 100% Achieved
ensuring the safety and reliability of products throughout their entire lifecycle.
Sustainable Supply Chain
Zhonghong Medical continues to improve its supply chain management system, proactively identifying potential risks and In 2025 Zhonghong Medical integrates environmental and social considerations deeply into the
growth opportunities. We build a resilient supply chain through diversification and rapid response systems, capture new growth supplier admission process. The Company rigorously reviews suppliers for environmental
from digitalization and sustainability, and unite our partners around a shared ESG vision. Potential suppliers disqualified compliance and labor rights protection, prioritizing partners with ISO 14001 certification. During
due to social responsibility the cooperation process, the Company strengthens dynamic supervision of environmental
non-compliance and social aspects through regular assessments, on-site audits, and special audits. Suppliers
Supplier management 0
are required to sign the Suppliers Social Responsibility Audit Checklist and the Supplier
Commitment to Compliance and Continuous Improvement of Social Responsibility and to
include environmental and social responsibility clauses in contracts to foster a responsible
According to the Supplier Management Control Procedure , Zhonghong Medical creates a comprehensive management supply chain.
mechanism that covers supplier entry, evaluation, auditing, incentives, and exit. A cross-departmental collaborative control Suppliers whose cooperation
model is in place to define responsibilities and boundaries at each stage. With dedicated teams and continuous training, the was terminated due to
Company has secured a solid foundation for supplier management. social responsibility non-
compliance
In 2025
Suppliers are initially screened based on technical and quality
Suppliers in total requirements. Qualification documents are collected and verified
Supplier selection
to ensure compliance.
and qualification
Supplier types, such as manufacturers, agents, and service providers,
review
are differentiated. Review standards are matched to the risk level of
materials, with on-site inspections conducted for high-risk categories.
Local suppiers
S uppliers are classified into A/B/C tiers based on how their
materials affect product quality. Management, qualification reviews,
sample testing, and approval processes are all tiered accordingly.
classification,
Local procurement Once approved, suppliers are included to our qualified supplier list, On-site supplier audits
approval, and
and corresponding cooperation agreements are signed. Nationally
admission
recognized professional agencies are directly included in the scope
RMB million of collaboration, exempt from additional evaluation. Supplier social responsibility requirements
We continuously monitor supply quality, on-time delivery rates,
and service responsiveness and collect quality feedback and
Quality and
information related to the handling of unqualified products.
performance
For suppliers with quality issues, we issue corrective action notices,
tracking during
track the effectiveness, and initiate the exit process if corrective
cooperation
actions are ineffective. We also sign quality agreements according Employee rights Environmental responsibility Social value
to supplier tier to clarify responsibilities.
Compliance with national and Compliance with national and Participation in social
At the end of each year, we organize a multi-department evaluation local labor laws, international local environmental protection responsibility projects and
and score suppliers based on qualification validity, quality, service, and labor standards, and industry laws and regulations. charitable activities,to give back
Annual supplier delivery capabilities. regulations. Improvement in resource utilization to society.
re-evaluation Based on the scores, we reclassify suppliers. Those who do not meet Provision of fair wages, efficiency and implementation Strengthening of CSR
standards are eliminated, while those requiring improvements are given compliant working hours, and of energy-saving and emission- management across the
deadlines for corrective actions, which helps optimize the supplier pool. safe working conditions. reduction measures. supply chain, conducting
Prohibition of child labor, forced Standardization of production environmental and social
We create a file for each qualified supplier, archiving qualification labor, and other violations and waste disposal processes responsibility assessments
documents, agreements, evaluation reports, and other materials to adherence to the principle of and establishment of a waste of lower-tier suppliers, and
Supplier control
ensure traceability. fair employment. recycling and reuse mechanism. promoting collaborative
mechanism
We establish a backup supplier system, assigning backup suppliers for compliance throughout the
Control of carbon emissions
critical materials to mitigate the risk of supply chain disruptions. supply chain.
and adherence to low-carbon
production.
Supplier management process
Premium Service
In 2025 Zhonghong Medical drives its transformation through digitalization. We have established a
transparent procurement platform to achieve full-process visibility and control, supported by
Proportion of local suppliers regular inspections and random checks. Together, they reinforce the integrity safeguards. The
Company actively practices green procurement by selecting environmentally friendly materials
to reduce environmental impact. The Company also implements a localized procurement Zhonghong Medical is committed to putting the customer at the center, integrating premium service into every stage of its
%
strategy to optimize the supply chain layout and support local economic development, building operations. Through a full-cycle service system, multi-channel communication mechanisms, comprehensive protection of
a compliant, transparent, green, and resilient sustainable supply chain ecosystem. customer rights, and responsible marketing practices, the Company continuously optimizes its service capabilities and customer
Proportion of localized experience. We work to build customer trust through professional, efficient, and compliant services.
procurement Transparent procurement system
We adhere to the principles of "openness and transparency, standardization, collective
decision making, smooth processes, supervisory, and information sharing" to establish
Higher service quality and efficiency
a transparent procurement system.
Zhonghong Medical works across multiple areas, including product line optimization, technological innovation, stringent product
We have developed a transparent procurement platform that integrates information
quality control, supply chain and logistics management upgrades, service process improvements, and stronger after-sales support, to
release, process control, contract signing, and payment settlement. We ensure data
consistently elevate the quality of customer service. This ongoing effort has earned the trust and support of its customers.
security through separation of duties, tiered management, and dual confidentiality
mechanisms, enabling fully electronic and transparent procurement operations.
Improving the customer service process
We clearly outline the transparent procurement process, in which the requesting department
submits procurement applications with specific requirements. We evaluate potential suppliers In 2025
Refined pre-sales service Efficient in-sales service Comprehensive after-sales service
through multiple channels. After negotiations and contract signing, we issue orders, track
execution, and make payments upon receipt of satisfactory goods, as per the contract terms. Issued and collected We build professional service We have established a fast- We have developed a robust
customer satisfaction teams to offer comprehensive response order processing after-sales service system that
questionnaires product consultations and system to ensure the timely includes product operation training,
Green procurement system
tailored hospital admission and accurate reception, review, clinical technical support, prompt
We have established a green procurement policy that defines environmental plans. We also accurately align and handling of orders. We response to customer complaints,
protection principles, procurement standards, and supplier selection processes to with customer needs, assist also provide efficient delivery and closed-loop issue resolution,
ensure the materials and services we purchase meet environmental requirements. them in selecting the most services and real-time order which repeats purchases, and
Customer satisfaction rate suitable products, and provide tracking, allowing customers fosters positive word-of-mouth,
W
e prioritize suppliers certified to ISO 14001 environmental management systems.
full-cycle support throughout to clearly monitor product laying the foundation for long-term
the admission process. delivery progress. partnerships.
Localized procurement %
We actively increase the proportion of locally sourced raw materials and components Zhonghong Medical is customer-demand driven. We have built a multi-dimensional feedback
by prioritizing products and services from the local market, thereby supporting local system covering the full lifecycle of our products and services, enabling us to capture
economic development. customer concerns, particularly related to health and safety, in a timely and thorough manner.
We sign long-term cooperation agreements with high-performing local suppliers to
ensure the stability and reliability of our supply chain. Direct communication channels Exclusive service channels
During regular customer visits and business We provide 24/7 feedback access through
Responsible procurement
engagements, we proactively communicate online channels, including a customer service
with customers about product usage hotline, official WeChat account, and dedicated
experiences, existing issues, and suggestions service email. We also assign personnel to
Zhonghong Medical is committed to sustainable procurement. Through open communication, for improvement. We document handle the screening, categorization, and
targeted training, and end-to-end collaboration, we empower our suppliers and drive these interactions in a Customer recording of customer inquiries.
sustainability across the supply chain, building a responsible network based on mutual trust Communication Record Form and
and shared success. promptly relay the feedback to
the relevant departments.
Supplier communication Supplier training
Collaborative communication Industry communication channels
We strengthen communication and We actively organize supplier training
channels We actively participate in industry
collaboration with suppliers through activities that cover various aspects,
We have established regular exhibitions, academic conferences,
multiple channels, including phone calls, including quality management, supply
communication mechanisms with distributors and other events. We also engage with
text messages, emails, regular face- chain management, and technological
and agents. We hold monthly partner meetings healthcare professionals, industry experts,
to-face meetings, industry exhibitions, innovation, to enhance suppliers'
to gather consolidated feedback and market and peer companies to collect potential
and forums. These platforms allow both overall competitiveness.
demands from end customers, compiling the issues and areas for improvement identified
parties to share experiences, discuss
insights into a feedback summary report. during the product usage process.
issues, and jointly develop solutions.
Protection of customer rights
Zhonghong Medical places a high priority on safeguarding customer privacy and has established a comprehensive management
system covering the entire lifecycle of customer information. The Company has implemented a "centralized management, In 2025 Zhonghong Medical has also established a comprehensive after-sales service management
system, including the Customer Feedback Control Procedure and Customer Complaint Control
clearly defined responsibilities, and coordinated collaboration" approach and set up a dedicated privacy protection task force led
Customer complaints Procedure , which clearly define the handling process for customer complaints and emphasize
by department heads, clarifying the roles and responsibilities of market, sales, after-sales, IT, and other relevant departments. To
proactive problem resolution. A dedicated customer complaint team has been set up, with
ensure that all employees are well-versed in privacy protection requirements, the Company regularly conducts policy briefings
multiple channels for customers to reach out, including a hotline and email. For technical
and specialized training sessions. A secure and reliable customer information management system has been put in place,
issues encountered during product use, the customer service team guarantees a solution
featuring encrypted storage, tiered access control, and strict authorization protocols to prevent unauthorized access. Regular
within 24 hours, and more complex issues will have technical staff dispatched on-site within
internal audits and risk assessments are conducted to identify and mitigate potential vulnerabilities, ensuring that privacy Customer complaint
protection measures are effectively implemented. During the reporting period, the Company did not experience any incidents of resolution rate
customer privacy leakage. Zhonghong Medical upholds a philosophy of responsible marketing. From reviewing
% promotional materials and standardizing product labeling to enhancing service capabilities, the
Company takes a multi-faceted approach to ensure marketing integrity. Through institutional
Enhancing customer privacy protection controls, professional training, and end-to-end process management, we ensure authentic
communications, standardized product information delivery, and fulfillment of our corporate
social responsibility in marketing.
Standardized Following the principles of lawfulness, legitimacy, and necessity, we clearly inform customers of Practicing responsible marketing
information the purpose, scope, and use of the information being collected, and obtain their consent before
collection collection. No information unrelated to business operations is collected.
Ensuring authenticity of promotions
We have implemented a rigorous information review process that all product
materials used for external communications must be approved by the relevant
departments.
Tighter We employ advanced encryption technologies to store customer information and build a robust
storage security infrastructure. Firewalls, intrusion detection systems, and other protective measures are in We strictly follow the principles of "review before release" and "case-by-case
security place, with regular data backups and security checks to ensure the safety of stored information. approval," classifying content according to its intended audience to ensure all
promotional materials are accurate and truthful, preventing the dissemination of
false or exaggerated information.
Avoiding consumer misguidance
Strict We have implemented a tiered authorization system, granting information access based on job
access responsibilities. Employees can only access customer information relevant to their work, and all We adhere to strict brand standards in product marketing, ensuring proper use
control access is logged to facilitate traceability and accountability. of product information and identifiers—from brand names and trademarks to
slogans and packaging. This guarantees consistent brand representation across
all channels and regions, avoiding consumer confusion caused by inconsistent or
incorrect branding.
Transmission When sharing necessary information with partners, privacy protection agreements are signed
and sharing to define the scope of use and confidentiality responsibilities. Data transmission is encrypted to
management minimize the risk of information leakage.
Information Customer information that is no longer required is securely destroyed following established
destruction procedures. Paper records are shredded, and electronic files are permanently deleted, ensuring a
procedures complete information security lifecycle.
People-Centered
Approach for Unity
and Strength
Zhonghong Medical values the contributions and aspirations of every
employee. We drive corporate growth through talent and innovation
while supporting employee development with structured systems.
Through a comprehensive ecosystem for employee growth, we
strive to create a fair, inclusive, and human-rights-respecting
workplace, safeguard occupational health, safety and well-being,
and work with our employees to strengthen the foundation for
sustainable development.
Material topics
Equal employment and protection of rights and interests
Employee training and development
Occupational health and safety
Employee care
Contributions to UN SDGs
Employee Rights Protection Internship We select outstanding students through summer internships and university-enterprise
program collaboration programs, with high-performing interns given priority for full-time job opportunities.
Zhonghong Medical is committed to fostering harmonious, stable, and healthy labor relations. Focusing on core areas such as
human rights protection, compensation and benefits, transparent communication, and employee care, we strive to safeguard
the legitimate rights of every employee. By fostering a fair, open, and inclusive corporate culture, we aim to fully unleash the
potential and value of our workforce. B y participating in large-scale job fairs in universities and hosting on-campus recruitment
Campus
sessions, we strengthen university partnerships, attract new graduates, and build a pool of core
Compliance in employment
recruitment
talent for long-term development.
We publish recruitment information, including job postings, responsibilities, and qualifications,
In 2025 The Company strictly adheres to China’s Labor Law , Labor Contract Law , Regulations on the
on the "join us" section of our Company website, official WeChat, Weibo, and Douyin accounts to
Prohibition of Child Labor , and other applicable local laws and regulations. We also align with
ensure transparency and standardization in the hiring process.
Total employees the principles and spirit of international conventions such as the International Bill of Human
External We also deepen cooperation with leading job portals and medical industry-specific platforms to
Rights , the Universal Declaration of Human Rights , and the Convention on the Rights of
recruitment attract highly suitable candidates.
Persons with Disabilities . Guided by these standards, we have established and implemented
By aligning with national employment support policies, we expand available positions and provide
policies such as the Employee Recruitment Control Procedure and the Employee Handbook ,
employment services, with a focus on integrating rural labor and promoting job opportunities for
practicing recruitment that is fair, transparent, and open. Our expanded recruitment channel
Employees from ethnic key groups.
helps attract diverse talent and build a robust talent pool.
minorities
We strictly prohibit the employment of child labor. The rule "no recruitment of individuals under 18
years old" is explicitly stated in our Human Resources Management Measures . During the recruitment
process, candidate identity and age are thoroughly verified, and all hiring records and verification Internal We select and transfer technical and managerial professionals internally and encourage employee
materials are carefully maintained. Through this full-process control system, we effectively mitigate recruitment referrals to improve recruitment efficiency.
Disabled employees
labor-related risks. During the reporting period, no incidents of child labor occurred.
Total employee turnover rate
Labor rules
Number of male employees We have formulated the Human Resource Management Measures and the Control Procedure of Prohibiting Forced Labor to
ensure that all employment processes, including recruitment, hiring, compensation, promotion, and training, are conducted
Number of female employees fairly and responsibly. Any form of discrimination based on gender, age, ethnicity, region, marital status, or religious belief is
or abuse, providing all employees with equal opportunities for employment and development. In parallel, we actively promote
localization of overseas employees, strictly following local laws and regulations in compliance and HR management. In countries
such as Thailand, Mexico, and Malaysia, all new hires are local nationals, ensuring protection of their labor rights and fostering
a diverse, inclusive, and equitable workplace. During the reporting period, no incidents of forced labor, discrimination, or
Employees under 30 years old harassment occurred, and there were no significant labor disputes or human rights complaints.
Employees aged 30-50
Employees over 50 years old
In 2025
Passed the BSCI
factory audit
Number of domestic employees
Number of overseas employees
WRAP
certification for social
Certificate
responsibility
Compensation and benefits Employee Growth
Zhonghong Medical provides competitive salaries and growth opportunities. Policies such as the Employee Evaluation Management
Measures , and Management Measures for Compensation Assessment of Middle-level Managers clearly define the composition and
standards for basic and performance-based wages. Regular evaluations of job levels ensure that employee compensation is closely
Zhonghong Medical upholds talent as the key driver of development and In 2025
continuously refines a full-cycle talent management system encompassing
aligned with role, competencies, and performance. Additionally, we have established an efficient and scientific performance appraisal
selection, utilization, development, and retention. Policies such as the Employee Zhonghong Medical was awarded the
system, coupled with mechanisms for motivation, accountability, and communication, effectively attracting and retaining top talent.
Evaluation Management Measures , Career Development Management Rules ,
Employee well-being is one of our priorities: working hours are reasonably scheduled, wages are paid fully and on time, and social 2025 China Talent
Training Management Measures , and Measures for the Comprehensive Assessment
insurance, including pension, medical, work injury, maternity, unemployment, as well as housing provident fund are fully contributed.
and Management of Employees During Probation Period guide this process. With a Management Excellence
Employees are also guaranteed statutory leave entitlements such as sick leave, personal leave, marriage leave, maternity/paternity
leave, breastfeeding leave, and childcare leave.
robust training system, fair incentive mechanisms, and clear promotion pathways, Award.
we foster the continuous growth of both employees and the Company.
Democratic management
Employee training
Zhonghong Medical respects employees’ rights to freedom of association and collective bargaining, and has established the
Democratic Management System , Incentive-Suggestion System , and other related systems. The Company promotes democratic Zhonghong Medical has established the Training Management Measures and developed a dual-track training system combining
management underpinned by the Workers' Congress to engage employees in democratic management and supervision. We position-specific professional training and personal capability development. Through programs such as new employee
have set up a labor dispute arbitration and mediation committee, with mediation and supervision offices, to collect, report, and onboarding, professional skills enhancement, and management training, as well as targeted digital, managerial, and business
address issues on human rights, performance, and career advancement. A labor union has been formed and reached formal support courses, we equip employees with precise skills to grow. Training covers all levels and categories, including strategic
agreements with the Company on working conditions, compensation and benefits, and occupational health and safety, with a investment, R&D, marketing, HR, and finance, ensuring core business units are fully supported. Leveraging the "Zhonghong
collective contract signed with all employees. In 2025, two employee grievance incidents were resolved. Academy" platform, we offer a blend of online and offline courses across all business lines and job levels. Training includes
leadership development, professional skills, and general knowledge competencies, providing employees with comprehensive
Employee care
learning opportunities.
In 2025
Zhonghong Medical is committed to creating a warm and fulfilling workplace. Our "Staff Home" offers mental health counseling and
organizes a variety of activities such as parent-child sports events and National Day running competitions to help employees maintain Total training investment
a healthy work-life balance. Through the Presidential Fund, we provide support to employees in need, and the "Care Room" offers
female employees a space to meet special or temporary needs, continuously enhancing overall employee satisfaction.
RMB
Training sessions
"Gathering Talent at Zhonghong, Leading the Future" 2025 new employee orientation camp
Number of employee training
Total hours of employee training
Training coverage
"Visiting Zhonghong, Co-Creating the Future" university-enterprise cooperation program
— North China University of Science and Technology field research
Employee activities such as Chinese New Year fairs, holiday celebrations, and National Day running events
Promotion pathways
Zhonghong Medical has implemented the Career Development Management Rules , establishing a dual-track development model for
management and professional paths. The policy clearly defines the criteria and qualifications for both routine promotions and exceptional
advancement, providing transparency and motivating employees to enhance their skills. This ensures all employees have a clear roadmap
for career progression and encourages self-driven growth. Additionally, we have formulated a series of rigorous selection systems, including
the Job Descriptions for Zhonghong Medical Subsidiaries and Departments , the Frontline Official Selection Methods , and the Management
on Selection and Appointment for Middle-Level Management Posts to explore, train, and appoint talent. These systems enable employees to
continuously enhance their professional skills, technical expertise and management capabilities.
Management channel Professional channel
Grade
Management ladder Operations ladder Technical ladder
Level Rank Level Rank Rank ISO 45001 occupational health Signing of annual EHS responsibility agreements by safety officers and subsidiaries
and safety systems certification
Strategy
Middle
management
First level
engineer
Zhonghong Medical adheres to the principle of "safety first, prevention foremost, and comprehensive management." We
have developed a robust safety management network and implemented strategic plans including the Three-Year Action
Grassroots Second level and Implementation Program . These initiatives continuously enhance work safety measures, raise employee awareness of
management engineer occupational health, and foster a safe and healthy working environment.
Assistant Risk category Risk despcription Likelihood Response measures
engineer
regulations on work safety and relevant laws and regulations,
Increased
Zhonghong Medical's "dual-channel" career development Policy risk
occupational health, failure to identify
Low Short-term compliance
maintain full-process records of
and implement the latest legal occupational health and safety
costs.
requirements may result in regulatory management, and conduct
Occupational Health and Safety
penalties and legal liabilities. internal compliance audits.
Improper employee operation or failure
Conduct regular hazard
to correctly use personal protective
identification and risk
equipment in production workshops Increased
Operational inspections, update emergency
Occupational health and safety form the foundation for sustainable business development. Zhonghong Medical has established may lead to occupational diseases, Low Short-term operating
safety risk response plans, enhance intrinsic
a end-to-end occupational health management system to prevent occupational diseases, monitor employee health, and mechanical injuries, or hazardous gas costs.
safety measures, and strengthen
implement timely interventions. By promoting a strong safety culture, we ensure the physical and mental well-being of exposure, causing occupational health
employee safety culture training.
employees throughout the production process. During the reporting period, no major safety incidents occurred. harm or production accidents.
Governance Opportunity
category
Opportunity description Likelihood
Impact
period
Financial
impact
Response measures
Intelligent upgrades will reduce Increase investment in digital
Zhonghong Medical strictly complies with Chinese laws and regulations including the Law on Work Safety , the Fire Control Law , the Improved
workplace injuries, prevent and intelligent systems, continue
Law on the Prevention and Control of Occupational Diseases , the Regulations on the Safety Management of Hazardous Chemicals , operational
Corporate occupational diseases, improve upgrading automated equipment,
and the Regulations on Occupational Health Supervision in Workplaces . We have obtained ISO 45001 certification for occupational efficiency
reputation production efficiency and stability, Medium Long-term conduct comprehensive health
health and safety management and implemented internal management systems such as the Work Safety Management Measures, and long-
opportunity protect employees' health and safety, and safety training for all
Occupational Disease Prevention System , and the Occupational Disease Hazard Warning and Notification System . In addition, we term
and enhance the company’s public employees, and strengthen daily
signed the 2025 safety responsibility agreement with all departments, adopted a "dual responsibility per role" policy, and incorporated profitability.
image and reputation. safety compliance practices.
the number of work injuries, occupational diseases, and safety accidents into management performance assessments.
Impact, risk, and opportunity management
Zhonghong Medical integrates occupational health and safety management closely with business operations. We conduct
regular hazard identification and risk assessments, strengthen hazardous chemical management, and systematically identify and
evaluate all potential risks. By preventing, controlling, and eliminating safety hazards and occupational health risks, we safeguard
employees' health and rights.
Risk assessment and control
We implement a dual-prevention mechanism, regularly conducting comprehensive risk identification and
assessment. In accordance with the Risk Classification and Control Plan , we apply differentiated management for
safety risks of varying levels, intensifying the control of key security risks and improving intrinsic safety standards.
We strengthen occupational health and safety risk identification and control by completing annual workplace Organizing safety culture training
occupational disease hazard assessments. We classify occupational disease hazards and risks, compile a Job
Exposure to Occupational Disease List , and improve protective measures in a targeted manner.
Hazard inspection and mitigation Conducting safety emergency drills
Metrics and targets
We follow the Safety Risk Control and Hazard Mitigation Manual , regularly conduct safety and environmental
assessments, and systematically inspect for safety hazards. Inspections before holidays, during Work Safety Month,
and routine work safety compliance checks will be arranged. We also implement preventive measures to close
management loops. In 2025, nearly 100 safety issues were addressed and rectified.
Targets Progress in 2025
Zero incidents of general level or above in work safety Achieved
Emergency management 100% compliance with safety risk assessment results Achieved
We have established a comprehensive emergency management system, and developed both general and specialized Zero incidence of occupational diseases Achieved
contingency plans, including the Comprehensive Emergency Plan, Emergency Drill Plan for Environmental Incidents , 100% coverage of safety training for all employees Achieved
and Emergency Response Manual for Special Equipment Accidents . We define governance structures and response
procedures, and conduct regular emergency drills to enhance overall employee preparedness.
In 2025
Occurrence rate of general Work-related fatalities Work-related fatality Invested in employee work-
Occupational health management level or above safety over the past three rate over the past related injury insurance
production accident years three years
Apart from health check-ups for all employees and occupational health records, we also organize the pre-job, on-
the-job, and post-job occupational health examinations for hazard-exposed positions. Meanwhile, we improve
employee health awareness through occupational health education and occupational disease prevention campaigns.
RMB million
We have formulated the PPE Management Policy to ensure compliant distribution of standard and specialized Rate of dangerous operation Inspection rate of special Training rate of occupational health for workers exposed
protective gear, while conducting regular inspections and maintenance of protective equipment. personnel holding relevant equipment and facilities to occupational hazards
certificates
Safety culture development
% %
Participants of the Total hours of employee safety Safety emergency Participants in safety drills
We develop an annual safety training plan and conduct at least one comprehensive safety training session across the employee safety training training drills
workforce. Training covers laws and regulations, job-specific safety procedures, and emergency response measures,
cultivating a workplace culture where everyone prioritizes safety.
hours
Responsibility First
Guided by Our
Original Mission
Zhonghong Medical upholds an open, collaborative, and
shared-responsibility approach, deeply cultivating the industry while
giving back to society. Built on our strengths, we strive to improve
access to healthcare, coordinate upstream and downstream efforts,
and promote high-quality development across the sector. By
delivering health with care, we translate our responsibility into
tangible actions that benefit society and enhance people's
well-being, collectively building a sustainable and healthy future.
Material topics
Healthcare accessibility
Industry development
Support for community-based charity
Contributions to UN SDGs
Healthcare Accessibility
Zhonghong Medical focuses on the protective needs of the healthcare industry and has established a comprehensive healthcare
We are driving the R&D and industrialization of multiple products, including food-grade nitrile
accessibility management system. We optimize our product portfolio to become the most complete supplier of medical gloves Advancing new
gloves, ultra-thin nitrile gloves, and specialty nitrile gloves. A total of 10 new products have
in China. By leveraging technological innovation, we enhance equitable access to healthcare, aligning supply with the economic product development
been investigated across infusion lines and production lines.
development, market characteristics, and healthcare levels of the regions where we operate. We also facilitate the distribution
of high-quality medical resources, and have been recognized as a V-level client by the China Export & Credit Insurance Responding to volume- We actively participate in more than 11 national and provincial-level procurement projects,
Corporation. We work hard to ensure that safe and efficient medical products and services reach a broader population. based procurement with over 10 products selected and more than 120 additional medical institutions served.
Expanding product coverage
We are building an integrated online-offline network with multiple tracks. SPD (Supply,
Innovating in channel Processing, Distribution) partner hospitals now exceed 40, and we are expanding into
models emerging markets such as private healthcare and veterinary medicine, establishing new
Zhonghong Medical continuously optimizes its global supply network and service collaborations with 15 private healthcare groups.
infrastructure, strengthening regional warehousing, distribution, and support systems to
enhance product accessibility and supply stability. Through diversified channels and innovative We have developed three product matrices: high-end innovative, core profit-driving, and basic
Optimizing product
products and services, we attract more potential customers and expand product reach, essential products. For tertiary hospitals, we launched four high-value new products tailored
portfolio
delivering high-quality products to support global public health cause. to meet diverse market needs.
Through refined supply chain management, we maintain reasonable procurement costs while
Product accessibility Ensuring stable
??个
leveraging modern logistics technologies, including IoT and big data analytics, to improve
In 2025 supply and logistics
transportation efficiency and ensure on-time, safe delivery to customers.
German Russian
O?ce O?ce
Products were sold in UK O?ce
Hungarian
Dutch O?ce
Company
+ countries
French
O?ce
Group Headquarters
Focusing on specific needs
and regions, including Spanish
O?ce
Tangshan Production Base
Shanghai Company
North America, Europe, Canadian O?ce Zhonghong Medical prioritizes the needs of key populations and diverse healthcare scenarios. Leveraging strong R&D
Tunisia Guilin Japanese Mexican O?ce
the Middle East, Japan, O?ce Production Base O?ce
Jiujiang Production Base
capabilities, we address domestic technological gaps in relevant fields and continually launch safe, reliable, practical, efficient,
American Company
Italian Yichun Production Base
and Africa. O?ce
Kazakhstan Thailand
Hong Kong
Company and cost-effective medical devices.
Jordanian O?ce Production Base
Shenzhen Production Base
O?ce
Hainan
Company
The production base in Brazilian O?ce
Southeast Asia is under
Malaysian
construction
Medispo protein non-detectable gloves Huadum high barrier condom
+ O?ce
The gloves use the industry's advanced decomposition Featuring a threelayer protective
domestic hospitals, Singaporean
Company
Chile O?ce
and detachment technology of protein to fully reduce structure, it effectively prevents the
including national and Argentinian O?ce
allergens and lower risks for people allergic to latex. penetration and transmission of HIV.
provincial benchmark
hospitals, were newly
engaged or under stable Company / O?ce
Medispo polyisoprene gloves
Production Base Long-life, high-performance
collaboration. The gloves are made of ultra?soft polyisoprene extended nuclear protection gloves
and contain no natural rubber latex, making them
Overseas clients Built with highly efficient nano?scale
suitable for people with latex allergies.
Product portfolio
nuclear radiation shielding materials
reinforced by a high?strength rubber
approx. Health protection Safe infusion Innovative incubation
Medispo KBD gloves matrix, the gloves deliver outstanding
The gloves use the positive charge generation anti?permeation and chemical resistance.
With subsidiaries established M
edical examination Infusion sets Infusion pumps
technology to protect healthcare professionals
in Beijing, Hong Kong (China), gloves Syringes Syringe pumps
while reducing incision infections. They are suitable
the United States, and the Medical surgical gloves Indwelling needles Nutrition pumps
for high-risk surgeries susceptible to infection. Long-life, high-performance
M
edical radiation Blood collection tubes Medical sensor consumables
neoprene glove box gloves
protection gloves Nasal oxygen cannula and lead wires
Netherlands, and + Made from premium imported neoprene
N
on-medical protective Sterilized connectors DS50 Series workstations Medispo radiation protection gloves
offices worldwide, the latex, these gloves pose a minimal risk
gloves Disposable nebulizers Digital temperature With high radiation protection performance,
Company ranks among the of allergic reactions and are suitable for
Polyisoprene gloves … management solutions the gloves are suitable for interventional and
world's top manufacturers harsh working environments involving
Condoms Disposable medical diagnostic radiology procedures, protecting
with an annual output of over heavy oils, strong acids, and strong bases.
Finger cots temperature sensors healthcare professionals from radiation exposure.
ten billion gloves. … …
Reducing healthcare costs Industry association Membership
China Rubber Industry Association Chairman unit, Chairman member of Latex Branch
Zhonghong Medical, while ensuring product quality, continuously reduces costs through process improvements and lean
management. This enables more primary-level healthcare institutions and price-sensitive users to access safe and reliable medical Chinese Chemical Society Member
products at affordable prices. By leveraging large-scale orders, we drive supply chain integration and optimize production processes,
effectively controlling overall operating costs. The average price of products selected for volume-based procurement has decreased Hebei Emergency Industry Alliance Vice chairman member
by approximately 40%, significantly alleviating the purchasing burden on medical institutions and reducing economic pressure on
Safety and Health Protection Products Committee of
patients. Considering overseas market conditions, per capita income, and local healthcare levels, we set differentiated and reasonable Member
China Textile Business Association
pricing aligned with regional development. We actively participate in local government tenders, gradually improving health awareness
in emerging markets and developing countries through affordable product pricing. Malaysian Rubber Glove Manufacturers Association
Member
(MARGMA)
Promoting health awareness
Zhonghong Medical, guided by its responsibility within the healthcare industry, actively participates in academic exchanges and Integrating industry and education to foster sustainable innovation
professional forums, sharing practical achievements and engaging in in-depth discussions with industry experts and researchers.
Based on our official website, social media, and other public communication platforms, we continuously disseminate health To strengthen the talent foundation and empower long-term development, Zhonghong Medical actively builds
knowledge and promote the proper use of medical devices. We integrate health-focused public initiatives with professional university-enterprise cooperation platforms. We have established deep collaborative relationships with organizations
services, conducting diversified health education and community outreach programs. In collaboration with authoritative such as Shenzhen Technology University and Shenzhen Polytechnic, exploring an innovative "industry-education-
academic institutions and medical associations, we provide specialized training for doctors in key clinical departments, helping research" model. By integrating academic intellectual resources with real-world corporate practice, we facilitate
improve public health literacy and the service capabilities of healthcare professionals. seamless connections between theoretical research, technological R&D, and industrial application. This approach
creates a talent pool precisely aligned with industry needs, continuously enhancing our capacity for technological
In 2025 problem-solving and innovation.
Posts per month on WeChat Posts per month on WeChat Covering diverse health knowledge including
Official Account Channels the safe use of medical devices, general
healthcare knowledge, physical health, nasal
health, allergy tips and body protection. Zhonghong Kelun and Yichun University co-create an industry-education-
research practice base
Win-Win Collaboration
In October 2025, Zhonghong Kelun officially launched the Yichun University Teaching Practice Base, initiating
comprehensive collaboration in talent development and technological innovation. Currently, four PhD students are
based at Zhonghong Kelun, working on optimizing existing products, applying and developing new materials, and co-
developing new products. This collaboration effectively links university research outcomes with real corporate needs,
accelerating the industrial application of innovative technologies.
Zhonghong Medical adheres to an open, collaborative, and mutually beneficial development philosophy, actively building a multi-
faceted industrial ecosystem. We deepen industry–academia–research cooperation to integrate scientific research outcomes
with industrial practice. Through participation in domestic and international industry exhibitions, we strengthen exchanges with
Social Welfare Engagement
supply chain partners, customers, and industry institutions, expanding collaboration opportunities and sharing development
benefits. The Company also contributes to the development of industry standards, using practical experience to support the
improvement of standard systems, thereby promoting standardization and high-quality development in the healthcare sector.
Guided by the core principle of "Protecting Health, Giving Back to Society," Zhonghong Medical actively fulfills its corporate
social responsibility and deeply integrates into local community development. Through volunteer services, cultural initiatives,
and targeted support programs, we build bridges for positive interaction with the community, contributing to an inclusive,
We organized or participated in nearly 50 domestic and international exhibitions, academic conferences, and brand caring, and sustainable social ecosystem.
events, reaching 3,000+ customers.
We led the drafting of the industry standard, Norm of Energy Consumption Per Unit Production of Latex Products ,
which was submitted to the China Rubber Industry Association for public consultation. Guilin HBM: Volunteer service lights up the reading room
We participated in the formulation of voluntary national standards Natural Rubber Latex Cleanroom Gloves , Nitrile
Cleanroom Gloves , Single-use Rubber Gloves for General Applications and the obligatory national standard,
To promote the spirit of volunteerism and cultivate a positive corporate culture, Guilin HBM actively carries out
Medical Gloves Safety Technology Requirements .
volunteer activities to support the development of staff reading rooms. These initiatives enrich employees' cultural
As a principal drafting organization, MedRena participated in developing the industry association group standard
and intellectual life while fostering a sense of mutual assistance and social responsibility.
Infusion Information Collection System .
Sound Governance
for Honest
Operations
Sound corporate governance forms the foundation for sustainable
growth and serves as the core support for navigating complex
market landscapes and aligning stakeholder interests. Zhonghong
Medical consistently upholds integrity, compliance and business
ethics, continuously optimizing its governance system and
organizational structure. The Company strengthens internal controls
and risk management, enhances operational transparency and
accountability and safeguards high-quality growth through standard
and efficient governance practices.
Material topics
Corporate governance
Investor relations management
Operational compliance
Business ethics and anti-corruption
Information security
Contributions to UN SDGs
Governance Foundation
In 2025
Average tenure of Board members Standard deviation of the ages of directors and senior management
Zhonghong Medical strictly adheres to Chinese laws and regulations, including the Company Law, Securities Law, Code of
Corporate Governance for Listed Companies, and the Rules Governing the Listing of Shares on the ChiNext Market of Shenzhen
Stock Exchange . Accordingly, we work to build a transparent, responsible, and efficient modern governance mechanism to
Board meetings convened Director attendance rate
continuously enhance the effectiveness of corporate governance.
Corporate governance
Strategy and Sustainability Remuneration, Appraisal and Nomination Audit Committee meetings
In accordance with internal regulations such as the Articles of Association , the Rules of Procedure for the Shareholders' Meeting Committee meetings convened Committee meetings convened convened
and the Rules of Procedure for the Board of Directors , Zhonghong Medical continues to refine supporting rules, including the Rules
of Procedure for Board Committees and the Management Measures for Controlling Subsidiaries . In line with the newly revised
Company Law , the Company prudently abolished the Board of Supervisors, with its supervisory functions fully assumed by the Audit
Committee of the Board. The Company maintains a governance structure centered on the Shareholders' Meeting, the Board of
Directors and management. The Shareholders' Meeting serves as the highest authority, the Board acts as the core governance body All meetings were in compliance with the Rules Governing the Listing of Shares on the ChiNext Market of Shenzhen Stock
and regularly reports to the Shareholders' Meeting, while the management is responsible for day-to-day operations, with clearly Exchange and the rules of procedure within their scope of authority.
defined responsibilities among all parties and coordinated operations. Specialized committees under the Board, including the Strategy
IR management
and Sustainability Committee, the Audit Committee and the Remuneration, Appraisal and Nomination Committee, coordinate key
internal functions such as strategic decision-making, audit oversight and sustainability management. In 2025, the Board reviewed and
approved matters including overseas greenfield and M&A projects, related-party transactions, senior executive remuneration plans
and the abolition of the Board of Supervisors, contributing to a stronger internal governance system.
The Board comprises nine members, including three independent directors and one female director. Director selection takes Zhonghong Medical continues to strengthen information disclosure and investor relations In 2025
into account diverse factors such as age, gender, educational background and profession. Board members possess extensive (IR) management by revising policies such as the Information Disclosure Management
Reports, announcements and other
experience in areas including industry operations, financial auditing, laws and regulations, and corporate management. They System and the Investor Relations Management System . The Company standardizes
documents issued on Shenzhen Stock
possess the professional knowledge and comprehensive capabilities required to fulfill their duties. The Company has revised the disclosure of financial and non-financial information, including strategic initiatives,
Exchange
material matters, operational developments and financial performance, to enhance our
the Rules for the Special Meeting of Independent Directors , regularly assesses and reports on Board independence and further
improves support mechanisms to ensure that independent directors effectively perform their duties. All directors attend relevant transparency. Through brokerage strategy meetings, roadshows and earnings briefings,
meetings in accordance with regulatory requirements and regularly participate in training on laws, regulations, and compliance. the Company deeply engages in the communication with institutional investors. We also
They exercise their powers prudently and perform their duties in a standardized manner. The composition and qualifications of regularly answer investor hotline calls and respond to inquiries on platforms, maintaining
the Board fully comply with applicable laws, regulations and the Articles of Association . efficient communication with both individual and institutional investors, safeguarding the
rights to information and returns of all shareholders, particularly minority shareholders.
Shareholders' Meeting
Operational Compliance
Strategy and Sustainability Committee
Board of Directors Remuneration, Appraisal and Nomination Committee
Zhonghong Medical steadfastly upholds law-based governance and a prudent operational strategy, embedding legal
Audit Committee
compliance and risk prevention throughout its operations. In response to evolving regulatory and environmental landscapes, we
The Management continuously refine our compliance systems and working mechanisms. By strengthening risk management and internal controls,
we strive to drive high-quality corporate development.
Compliance, internal control and risk management
Zhonghong Medical governance structure
Extended reading
Zhonghong Medical consistently regards compliant operations as a fundamental principle. Through a coordinated model of
For more governance and financial information, please refer to: Zhonghong Medical Annual Report 2025 or our
“institutional support, audit oversight, and cultural empowerment,” we have built a fullprocess compliance loop, covering
official website (https://www.zhonghongmedical.com/list-49-1.html ).
prevention, control, and post?event optimization, to strengthen risk management and internal controls. This integrated approach
establishes a solid compliance foundation that supports highquality development.
Revised the Guidelines on Compliance Risk Management , clarified the division of responsibilities and work
procedures of all levels in compliance management, established a normalized and institutionalized compliance Business Ethics
operation mechanism, and improved management efficiency.
Emphasized the operation of the Compliance Committee, promoted the appointment of Chief Compliance
Officers, and gave play to the role of compliance administrators in all departments and affiliated enterprises. Zhonghong Medical upholds business ethics and operates with integrity and compliance. The Company strictly prevents
Compliance Integrated compliance review as a mandatory procedure into the operation and management process, regularly corruption and commercial bribery, firmly opposes unfair competition, and strengthens information security. Built on end-to-
management evaluated compliance management work, and promoted the continuous improvement and effective operation end risk prevention and control mechanisms and standardized operations, we safeguard market order and protect the legitimate
system of the compliance management system. rights and interests of the Company and our stakeholders.
O rganized 4 special training sessions on law and compliance, and carried out various publicity and
implementation activities to enhance the legal and compliance awareness of all employees.
Improved and perfected the internal control system, issued the Internal Control Manual (2025 Edition) and
Anti-corruption
manual content matches business reality and regulatory requirements.
Optimized core business processes, streamlined approval links, clarified the responsibility boundaries and operation Zhonghong Medical strictly complies with laws and regulations on anti-corruption and anti-bribery. In accordance with policies
standards of each post, strengthened process time limit management, and improved execution efficiency. such as the Employee Code of Professional Ethics and the Integrity Risk Prevention Manual , the Company communicates its
Internal Gave play to the supervision role of internal audit, completed 8 internal audit projects throughout the year, zero-tolerance stance on corruption to employees and business partners. Internally, all employees are required to sign integrity
control accepted 5 external audits and inspections, included rectification items in the performance of persons in commitments. Through internal communications, integrity reminders, and warning education, the Company continuously
system charge, and achieved a 100% completion rate of rectification items within a time limit. reinforces anticorruption awareness. Externally, all procurement personnel sign the Integrity Commitment Letter, and business
S olidified internal control supervision and evaluation, organized internal control self-evaluation of the partners sign the Integrity Agreement . These measures strengthen integrity risk control in key areas such as procurement and
headquarters and 23 affiliated enterprises, and achieved full coverage of the self-evaluation scope. sales, and prevent misconduct including corruption, embezzlement, and bribery.
The Company has established
Launched the optimization of the risk management system, improved the basic risk management framework
public reporting email and hotline
with clear rights and responsibilities, smooth processes, comprehensive coverage and unified standards, and Reporting email: tsjb@zhonghongpulin.cn
channels—including email, letters,
significantly improved the speed and accuracy of risk identification, assessment and response.
and inperson reporting—to enable Reporting hotline: 0315-4169049
Strengthened the response to major risks, formulated more accurate, effective and company-preference-
customers, employees, and
compliant major risk response strategies, and enhanced the proactive management capability and decision-
suppliers to report misconduct. We
making level for major risks.
commit to strictly protecting the
Risk Updated risk monitoring indicators and early warning rules, formulated the Risk Monitoring Indicator Library ,
confidentiality of whistleblowers
management and quantitatively judged standards by checking the early warning rules and critical values of each indicator to
and reported information. All reports
system ensure that the early warning threshold range is closed and covers all scenarios.
are investigated in accordance
Carried out in-depth risk assessment, monitoring and comprehensive risk analysis, held regular meetings of the
with established procedures,
risk management working group, dynamically evaluated risk impacts, and promoted the practical improvement
with zero tolerance for shielding
of risk prevention and resolution capabilities.
any individual or misconduct.
IPR protection
Any unauthorized disclosure of
information or retaliation against
whistleblowers will be addressed
in accordance with applicable
Zhonghong Medical regards intellectual property rights (IPRs) as the key to technological innovation and core competitiveness. The Company laws and regulations.
strictly complies with Chinese laws and regulations, including the Patent Law and Trademark Law, and has established a comprehensive
end-to-end IPR management system. IPR management is integrated into all stages of R&D, production and operations, with mechanisms in
Warning education
place for patent identification, application and protection. The Company strengthens IPR risk prevention, standardizes trademark usage and
trade secret protection and regularly conducts IPR training covering all roles in R&D, production and marketing, reinforcing company-wide
Anti-unfair competition
IPR compliance and awareness. During the reporting period, the Company encountered no major IPR infringement or conflict cases.
In 2025
Invention patents Utility model patents 2025 Jointly formulated standards
The Company upholds compliant operations and explicitly prohibits unfair competition practices such as false advertising,
Safety Technical Requirements for Medical Gloves (GB 24788-2025)
Nitrile Cleanroom Gloves (GB/T 46165-2025)
Natural Rubber Latex Cleanroom Gloves (GB/T 46166-2025)
abuse of power, commercial bribery and infringement of trade secrets. We have established a full-process mechanism covering
risk identification, violation handling and accountability. In market competition, we respect competitors and refrain from
disseminating false information that could damage their reputation through social media, news outlets or other channels,
Design patents applied Academic papers published
Single-use Rubber Gloves for General Applications (GB/T 46059-2025) thereby safeguarding a fair business environment and the legitimate rights of market players. In 2025, the Company had no
Fair competition Regular risk inspection
Key Performance Table
We improved the compliance review mechanism for We regularly conducted risk inspections related to unfair
marketing activities. All marketing plans, promotional competition, focusing on key areas such as sales, bidding Economic
materials and bidding documents were reviewed and and promotion. We maintained risk inspection records
approved by the Legal Department prior to release or and promptly implemented corrective measures, forming Indicator Unit 2024 2025
submission to ensure compliance. a closed-loop management process across inspection,
Revenue RMB million 2,456.6507 2,373.2068
rectification and review.
Total assets RMB million 7,230.3608 7,437.7981
Owner's equity RMB million 5,620.6856 5,421.6962
Business secret protection Compliance awareness
Total profit RMB million -66.9034 -124.1092
We clearly defined the scope of trade secrets, signed We regularly conducted training on anti-unfair competition,
Net profit RMB million -85.8304 -116.4773
confidentiality agreements with key employees, strengthened using case studies and compliance interpretations to educate
security of office environments and information systems and employees on relevant laws and regulations, enhancing Net profit attributable to shareholders of the parent company RMB million -87.1289 -112.3832
standardized handover procedures for departing employees compliance awareness across the workforce.
to prevent the leakage of trade secrets. Environmental
Indicator Unit 2024 2025
Total environmental investment RMB 10,000 1,008.82 2,257.33
Information security
Total GHG emissions tCO2e 818,075.31 851,780.57
Scope 1 GHG emissions tCO2e 9,453.28 3,206.49
Zhonghong Medical is certified to ISO 27001 Information security management systems. We continuously optimize our system Scope 2 GHG emissions tCO2e 808,622.03 848,574.08
through training and communication, implementation, audit-based supervision and continuous improvement. Our annual
GHG emission intensity tCO2e/RMB 10,000 3.3300 3.5892
information security training and cybersecurity emergency drills cover all employees, enhancing their awareness and incident
response capabilities. We have also established the Security Operations Center (SOC), with such security equipment in place Total wastewater discharged m3 2,553,541.44 2,792,250.90
as firewalls, intrusion detection systems and vulnerability scanning tools. Through routine inspections, regular vulnerability
scanning and remediation, and biannual special audits, we endeavor to build a robust information security protection system. In Total industrial wastewater m3 2,330,200.54 2,519,299.21
Total domestic wastewater m3 223,340.90 272,951.69
The Company respects and protects the privacy of its stakeholders. The data collection, retention, processing and sharing are
Total waste ton 3,041.05 2,965.35
conducted with the informed consent of relevant parties, and all data sources are legally compliant. Measures such as data
encryption, off-site backup and access control are implemented to secure safety management throughout data lifecycle. Total hazardous waste ton 1,276.65 764.43
Intensity of hazardous waste ton/RMB 10,000 0.0052 0.0032
Total non-hazardous waste ton 1,764.40 2,200.92
We conducted a special information security audit covering all critical information systems and
Internal audit
timely rectified 8 identified issues. Intensity of non-hazardous waste ton/RMB 10,000 0.0072 0.0093
Coal consumption ton 1,619.48 0.00
We organized 4 company-wide information security training sessions on topics such as basic Gasoline consumption L 6,578.66 23,514.98
Awareness cybersecurity knowledge, phishing email recognition, malware prevention and data protection
Diesel consumption L 59,997.43 61,129.77
training practices.
We held the “Cybersecurity Week” campaign in forms of posters, case sharing and knowledge Natural gas consumption m3 346,615.00 110,630.45
competitions to raise employees’ cybersecurity awareness.
Consumption of coke oven gas m3 6,026,192.00 3,203,744.00
Purchased electricity MWh 363,324.69 398,951.91
Emergency We conducted a data breach emergency drill where we simulated the data leakage emergency of core Steam consumption ton 2,019,403.85 2,138,596.71
drill customers, and optimized our emergency response plans based on issues identified during the exercise.
Direct energy consumption tce 5,401.93 2,217.06
Environmental Social
Indicator Unit 2024 2025 Indicator Unit 2024 2025
Indirect energy consumption tce 242,501.18 255,436.15 Participants in volunteer activities headcount - 13
Total energy consumption tce 247,903.11 257,653.20 Hours of volunteer activities hour - 26
Energy intensity tce/RMB 10,000 1.0091 1.0857 Total tax payment RMB million 46.7684 54.0523
Clean energy usage MWh 3,751.00 1,197.22 Total number of suppliers - 958 934
Packaging materials used ton 18,533.02 13,643.71 Percentage of products withdrawn and recalled due to health and safety reasons % 0 0
Total water consumption ton 2,541,786.74 2,941,536.94 Customer complaints time - 306
Domestic water consumption ton 304,806.94 295,803.64 Customer complaint resolution rate % 100 100
Industrial water consumption ton 2,236,979.80 2,645,733.30 R&D investment RMB million 98.3142 113.1865
Water resource utilization intensity ton/RMB 10,000 10.3466 12.3948 Proportion of total R&D investment to main business revenue % 4.00 4.77
Social R&D personnel headcount 516 625
Indicator Unit 2024 2025 Proportion of R&D personnel % 12.20 16.09
Total employees headcount 4,228 3,884 Total invention patents - 63 64
Male headcount 1,443 1,378 Number of invention patent applications - 10 4
Female headcount 2,785 2,506 Number of authorized invention patents - 12 14
< 30 years old headcount 444 389 Number of valid patents - 225 240
> 50 years old headcount 311 366 Indicator Unit 2024 2025
Number of dispatched employees headcount 39 32 Total directors headcount 9 9
Employees from ethnic minorities headcount 173 208 Total female directors headcount 2 1
Number of employees with disabilities headcount - 44 Total independent directors headcount 3 3
Stock pledge ratio % 0 0
Total employee turnover rate % - 29.05
Shareholders' Meetings held time 4 5
Investment in work-related injury insurance for employees RMB million 1.9895 2.1929
Announcements and reports, etc. released on the exchanges - 155 193
Coverage rate of work-related injury insurance % 97.28 93.77
Amounts involved in data security incidents RMB million 0 0
Work-related fatalities headcount 0 0
Number of major litigation, arbitration and other risk events involved - 0 0
Work-related fatality rate % 0 0
Number of violations and total fines paid RMB 0 0
Employee training expenditure RMB 224,800 229,800
Directors trained in anti-commercial bribery and anti-corruption headcount 9 9
Employee training sessions time 403 432
Percentage of directors trained in anti-commercial bribery and anti-corruption % 100 100
Total employees trained headcount 2,826 2,321 Management personnel trained in anti-commercial bribery and anti-corruption headcount 30 32
Employee training coverage rate % 66.84 59.76 Percentage of management personnel trained in anti-commercial bribery and
% 100 100
anti-corruption
Average hours of training per year per employee hour 4.68 7.55
Employees trained in anti-commercial bribery and anti-corruption headcount 4,228 3,884
Percentage of employees receiving regular performance and
% - 41.92 Percentage of employees trained in anti-commercial bribery and anti-corruption % 100 100
career development reviews
Indicator Indexes GRI Standard Disclosures
Page/remark
GRI Content Index GRI 2：
General disclosures 2-27 Compliance with laws and regulations 59-62
Zhonghong Medical has prepared this report in accordance with the GRI Standards for the period from
Statement of use
January 1, 2025 to December 31, 2025. 2-29 Approach to stakeholder engagement 12-13
GRI 1 used GRI 1: Foundation 2021
GRI 3: 3-1 Process to determine material topics 11-12
Material Topics 2021 3-2 List of material topics 12
GRI Standard Disclosures Page/remark
Economic
GRI 204 Procurement 3-3 Management of material topics 34-36
Practices 2016 204-1 Proportion of spending on local suppliers 36
No restatements of information during
the reporting period 205-1 Operations assessed for risks related to corruption 61
GRI 205 Anti-
and procedures
GRI 206 Anti- 3-3 Management of material topics 61-62
competitive Behavior 206-1 Legal actions for anti-competitive behavior, anti-trust, and
monopoly practices
Environmental
GRI 2： 2-11 Chair of the highest governance body 58 3-3 Management of material topics 23
General
disclosures 58 GRI 301 Materials
management of impacts
GRI 303: Water and
GRI Standard Disclosures Page/remark GRI Standard Disclosures Page/remark
GRI 303: Water GRI 403: directly linked by business relationships
and Effluents 303-4 Water discharge 24、63 Occupational 403-8 Workers covered by an occupational health and safety management system 46-47
Safety 2018
and Education
GRI 305: 404-3 Percentage of employees receiving regular performance and career
Emissions 2016 305-4 GHG emissions intensity 23、63 development reviews
Diversity
Opportunity Confidentiality restrictions
emissions Report
GRI 406: Non- 3-3 Management of material topics 43
GRI 408: Child 3-3 Management of material topics 42
GRI 306: 306-2 Management of significant waste-related impacts 24
Labor 2016 408-1 Operations and suppliers at significant risk for incidents of child labor None
Waste 2020 306-3 Waste generated 24、63
GRI 409: Forced 3-3 Management of material topics 43
Labor 2016 None
GRI 308: Supplier GRI 413: Local 413-1 Operations with local community engagement, impact assessments,
Environmental 308-1 New suppliers that were screened using environmental criteria 35 Communities and development programs
Assessment 2016 2016 413-2 Operations with significant actual and potential negative impacts on
local communities
Social
GRI 414: 3-3 Management of material topics 35
Assessment
GRI 401: 401-1 New employee hires and employee turnover 42 2016 414-2 Negative social impacts in the supply chain and actions taken 35-36
Employment 401-2 Benefits provided to full-time employees that are not provided to 3-3 Management of material topics 37
temporary or part-time employees GRI 416: 416-1 Assessment of the health and safety impacts of product and service
Customer Health categories
and Safety 2016 416-2 Incidents of non-compliance concerning the health and safety
impacts of products and services
GRI 417: 417-1 Requirements for product and service information and labeling 39
GRI 403: Marketing and 417-2 Incidents of non-compliance concerning product and service
Occupational 403-3 Occupational health services 48-49 Labeling 2016 None
information and labeling
Health and
Safety 2018 48
occupational health and safety
GRI 418: 3-3 Management of material topics 38
Privacy 2016 None
losses of customer data
Content Index of the Self-Regulatory Guidelines
No. 17 for Companies Listed on Shenzhen Stock
Exchange—Sustainability Report (For Trial
Implementation)
Dimension No. Topics Corresponding terms Page
Environmental
Social 13 Supply chain security Article 45 34-36
Sustainability- 19 Stakeholder engagement Article 53 12-13
related
governance 20 Anti-commercial bribery and anti-corruption Article 55 61
This report is printed on environmentally friendly paper.
Address:Southwest of the intersection of Zhongdajie and Jinxiu Road, Luannan
Economic Development Zone, Tangshan City, Hebei Province, China.
Zip code: 063500
首页
微信公众号
证券之星APP
